The primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) complication measure assesses risk-standardized complication rates (RSCRs) for individual clinicians or groups of clinicians to improve the quality of care delivered to their patients.
This re-specified measure includes THA/TKA procedures performed in both inpatient and outpatient (hospital outpatient department and Ambulatory Surgery Centers [ASC]) settings among eligible Medicare Fee-For-Service (FFS) beneficiaries who are at least 65 years of age.
The measure captures specific coded complications that occur at the index admission/encounter or during a readmission, observation stay, emergency department (ED) visit, or ASC encounter.
Measure Specs
- General Information(active tab)
- Numerator
- Denominator
- Exclusions
- Measure Calculation
- Supplemental Attachment
- Point of Contact
General Information
The goal of the Risk-standardized Complication Rate (RSCR) following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) for Eligible Clinicians and Eligible Clinician Groups measure (hereafter referred to as THA/TKA Complications measure for ECs and EC Groups) is to improve patient outcomes by providing patients, physicians, hospitals, and policymakers with information about RSCR following primary elective THA and/or TKA. More specifically, the measure aims to improve patient outcomes by providing more information about serious complications that require facility-based care following primary elective THA and TKA.
The list of serious complications included in the measure was adopted based on those complications identified from the medical literature and in consultation with a working group and technical expert panel during the development of the Hospital-level Risk-standardized Complication rate (RSCR) following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) (CBE#1550) (hereafter referred to as Hospital-level THA/TKA Complications measure). Measurement of patient outcomes allows for a broad view of the quality of care that encompasses more than what can be captured by individual process-of-care measures. Complex and critical aspects of care, such as prevention of and response to complications, communication between clinicians, patient safety, and coordinated transitions to the outpatient environment, all contribute to patient outcomes but are difficult to measure using individual process measures. While most clinician-level quality improvement measures for patients undergoing elective THA and TKA procedures are generally focused on evidence-based processes of care, this measure informs quality improvement efforts targeted toward minimizing medical and surgical complications during surgery and the postoperative period for patients who have undergone THA and/or TKA.
This measure identifies Eligible Clinicians (ECs) or EC Groups responsible for the patients’ care and evaluates whether their performance is better or worse than would be expected based on each clinician’s patient case mix and therefore promotes clinician-level quality improvement.
THA and/or TKA complications are a priority area for outcome measure development. It is an outcome that is reasonably attributable to surgeons who perform the procedure and is an important outcome for patients. Measuring and reporting rates of serious complications after THA/TKA procedures performed by ECs or EC Groups informs healthcare clinicians and facilities about opportunities to improve care, strengthens incentives for quality improvement and ultimately improves the quality of care received and outcomes experienced by Medicare patients.
THA and TKA are commonly performed and costly procedures. According to the CMS Medicare/Medicaid Part B National Summary, in 2019 the annual volume of primary TKA was 480,958 and that of primary THA was 262,369 with forecasts suggesting an increase in demand for procedures due to gains in post-surgery care, the aging population, and increasing rates of osteoarthritis (Shichman et al., 2023). Complications following a THA/TKA can vary in frequency and drive the overall cost of these procedures, leading to a substantial burden on both the patient and the healthcare system (Schwarzkopf et al., 2019). Improving complex and critical aspects of care, such as communication between clinicians, rapid response to complications, patient safety, and coordinated transitions to the outpatient environment, all contribute to better patient outcomes (Ozdag et al., 2024; Zheng et al., 2019; Antonelli et al., 2019; Elbuluk et al, 2019). Complications increase costs associated with THA and TKA procedures and affect the quality of life for patients (Bumpass et al., 2012; Shearer et al., 2015). Although complications following elective primary THA and TKA are rare, the results can be devastating (Kurtz et al., 2012; Helwig et al,. 2014; Elsiwy et al., 2019).
CMS implemented this measure in the Merit-based Incentive Payment System (MIPS) in 2021 because preventing complications of care following THA and TKA procedures reduces costs and promotes high-quality care and better patient outcomes.
A series of changes announced in the Calendar Year (CY) 2018 and CY 2020-2021 Hospital Outpatient Prospective Payment System (OPPS) Final Rules removed TKA and THA procedures from the inpatient-only list, allowing both procedures to be performed in the outpatient setting (Centers for Medicare & Medicaid Services, 2018; 2019; 2020). Subsequently, in CY 2020 CMS added TKA procedures and in CY 2021 THA procedures to the Ambulatory Surgery Center (ASC) covered procedure list, making both procedures billable in the ASC setting as well (Centers for Medicare & Medicaid Services, 2018; 2019). These changes resulted in a sizable increase in the number of THA/TKAs performed in the outpatient setting, providing a rationale for the expansion of the current THA/TKA complication measure for ECs and EC Groups (Suter et al., 2020).
The re-specification of this previously endorsed measure includes expanding the measure cohort and outcome definition to include the increasing number of procedures performed in hospital outpatient and ASC settings (Xu et al., 2019; Aynardi et al., 2014; Arshi et al., 2019; Bert et al., 2017; Goyal et al., 2017; Darrith et al., 2019; Migliorini et al., 2021; Mariorenzi et al., 2020).
References
Antonelli, B., & Chen, A. F. (2019). Reducing the risk of infection after total joint arthroplasty: preoperative optimization. Arthroplasty, 1(1). https://doi.org/10.1186/s42836-019-0003-7
Arshi, A., et al., Outpatient total hip arthroplasty in the United States: A population-based comparative analysis of complication rates. J Am Acad Orthop Surg, 2019. 27(2): p. 61-67.
Aynardi, M., et al., Outpatient surgery as a means of cost reduction in total hip arthroplasty: A case-control study. HSS J, 2014. 10(3): p. 252-5.s
Bert, J.M., J. Hooper, and S. Moen, Outpatient Total Joint Arthroplasty. Curr Rev Musculoskelet Med, 2017. 10(4): p. 567-574.
Bumpass, D. B., & Nunley, R. M. (2012). Assessing the value of a total joint replacement. Current Reviews in Musculoskeletal Medicine, 5(4), 274–282. https://doi.org/10.1007/s12178-012-9139-6
Centers for Medicare & Medicaid Services (CMS) HHS, Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Final Rule With Comment Period. Federal Register, 2018. 83: p. 58818-59179.
Centers for Medicare & Medicaid Services (CMS) HHS, Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Final Rule With Comment Period. Federal Register, 2019. 84: p. 61142-61492.
Centers for Medicare & Medicaid Services (CMS), H., Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Proposed Rule. Federal Register, 2020. 85: p. 50074-50665.
Darrith, B., et al., Inpatient Versus Outpatient Arthroplasty: A Single-Surgeon, Matched Cohort Analysis of 90-Day Complications. J Arthroplasty, 2019. 34(2): p. 221-227.
Elbuluk, A. M., Novikov, D., Gotlin, M., Schwarzkopf, R., Iorio, R., & Vigdorchik, J. (2018). Control Strategies for infection prevention in total joint arthroplasty. Orthopedic Clinics of North America, 50(1), 1–11. https://doi.org/10.1016/j.ocl.2018.08.001
Elsiwy, Y., Jovanovic, I., Doma, K., Hazratwala, K., & Letson, H. (2019). Risk factors associated with cardiac complication after total joint arthroplasty of the hip and knee: a systematic review. Journal of Orthopaedic Surgery and Research, 14(1). https://doi.org/10.1186/s13018-018-1058-9
Goyal, N., et al., Otto Aufranc Award: A Multicenter, Randomized Study of Outpatient versus Inpatient Total Hip Arthroplasty. Clin Orthop Relat Res, 2017. 475(2): p. 364-372.
Helwig, P., Morlock, J., Oberst, M., Hauschild, O., Hübner, J., Borde, J., Südkamp, N. P., & Konstantinidis, L. (2014). Periprosthetic joint infection—effect on quality of life. International Orthopaedics, 38(5), 1077–1081. https://doi.org/10.1007/s00264-013-2265-y
Kurtz, S. M., Lau, E., Watson, H., Schmier, J. K., & Parvizi, J. (2012). Economic burden of periprosthetic joint infection in the United States. The Journal of Arthroplasty, 27(8), 61-65.e1. https://doi.org/10.1016/j.arth.2012.02.022
Mariorenzi, M., et al., Outpatient Total Joint Arthroplasty: A Review of the Current Stance and Future Direction. R I Med J (2013), 2020. 103(3): p. 63-67.
Migliorini F, C.L., Cuozzo F, Oliva F, Valerio Marino A, Maffulli N, Outpatient Total Hip Arthroplasty: A Meta-Analysis. Applied Sciences, 2021. 11(15): p. 6853-6864.
Ozdag, Y., Makar, G. S., & Kolessar, D. J. (2024). Postoperative communication volume following total joint arthroplasty can be a precursor for emergency department visits. Arthroplasty Today, 27, 101352. https://doi.org/10.1016/j.artd.2024.101352
Schwarzkopf, R., Behery, O. A., Yu, H., Suter, L. G., Li, L., & Horwitz, L. I. (2019). Patterns and costs of 90-Day readmission for surgical and medical complications following total hip and knee arthroplasty. The Journal of Arthroplasty, 34(10), 2304–2307. https://doi.org/10.1016/j.arth.2019.05.046
Schwarzkopf, R., Behery, O. A., Yu, H., Suter, L. G., Li, L., & Horwitz, L. I. (2019). Patterns and costs of 90-Day readmission for surgical and medical complications following total hip and knee arthroplasty. The Journal of Arthroplasty, 34(10), 2304–2307. https://doi.org/10.1016/j.arth.2019.05.046
Shearer, D. W., Youm, J., & Bozic, K. J. (2015). Short-term Complications Have More Effect on Cost-effectiveness of THA than Implant Longevity. Clinical Orthopaedics and Related Research, 473(5), 1702–1708. https://doi.org/10.1007/s11999-014-4110-z
Shichman I, Roof M, Askew N, Nherera L, Rozell JC, Seyler TM, Schwarzkopf R. Projections and Epidemiology of Primary Hip and Knee Arthroplasty in Medicare Patients to 2040-2060. JB JS Open Access. 2023 Feb 28;8(1):e22.00112. doi: 10.2106/JBJS.OA.22.00112. PMID: 36864906; PMCID: PMC9974080.
Suter, L.G., et al., 90-Day Risk-Standardized Complication Rates Following Elective Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) for a Potential Combined Inpatient and Outpatient Episode Payment Model (EPM) Business Case. 2020.sXu, J., et al., Comparison of outpatient versus inpatient total hip and knee arthroplasty: A systematic review and meta-analysis of complications. Journal of Orthopaedics, 2019. 17: p. 38-43.
Zheng, Q., Geng, L., Ni, M., Sun, J., Ren, P., Ji, Q., Li, J., & Zhang, G. (2019). Modern instant messaging platform for postoperative follow-up of patients after total joint arthroplasty may reduce re-admission rate. Journal of Orthopaedic Surgery and Research, 14(1). https://doi.org/10.1186/s13018-019-1407-3
The measure uses administrative claims and enrollment data for measure reporting. For testing, we used Medicare administrative claims data and enrollment information for patients with qualifying procedures between April 1, 2019, and March 31, 2022, and extending through June 30, 2022, for the capture of complications. Specifically, we used the following data sources:
- Medicare inpatient, outpatient, and physician/professional claims: these include data for Medicare FFS inpatient and outpatient services such as Medicare inpatient hospital care, outpatient services, and physician claims for the 12 months prior to an index encounter and for the three months after. The professional claims are also used to identify the attributed clinician.
- Medicare Enrollment Database (EDB): This database contains Medicare beneficiary demographics, benefit/coverage, and vital status information. This data source is used to obtain information on several inclusion/exclusion indicators such as Medicare status on procedure, vital status at discharge, and death information post-discharge. This data has previously been shown to accurately reflect patient vital status.
Numerator
The outcome for this measure is any of the specified complications listed below occurring during the index encounter or are captured in claims that are associated with an index admission or readmission, observation stay, ED visit, or ASC encounter up to 90 days after elective primary THA and/or TKA procedures. Complications are defined as:
- Acute myocardial infarction (AMI), pneumonia, and sepsis/septicemia/shock complications within 7 days from the index procedure.
- Surgical site bleeding and pulmonary embolism within 30 days from the index procedure.
- Mechanical complications and periprosthetic joint infection/wound infection within 90 days of the index procedure.
- Death during the index admission or within 30 days from the index procedure.
The complication outcome is a dichotomous (yes/no) outcome. If a patient experiences one or more of these complications in the applicable time period, the outcome for that patient is counted in the measure numerator as a “yes”.
The outcome for this measure is any of the specified complications listed below that occur during the index encounter or during a post-procedure readmission, observation stay, emergency department (ED) visit, or ASC encounter after a qualifying elective primary THA and/or TKA procedure. As described below in detail, some of the complications are limited to capture from the inpatient setting only (AMI, pneumonia, sepsis/septicemia, shock).
The complication outcome is a dichotomous (yes/no) outcome. Therefore, if a patient experiences one or more of the following complications within the specific outcome window for each complication as defined below, the complication outcome for that patient is counted in the measure as a “yes”.
- Acute myocardial infarction (AMI), pneumonia, and sepsis/septicemia/shock: during the index encounter or within seven days from the index procedure (applicable to complications in the inpatient setting only because these events in the other settings likely do not represent serious clinical complications). The follow‐up period for AMI, pneumonia, and sepsis/septicemia/shock is seven days from the date of index encounter because these conditions are more likely to be attributable to the procedure if they occur within the first week after the procedure. Additionally, analyses indicated a sharp decrease in the rate of these complications after seven days.
- Death, surgical site bleeding, and pulmonary embolism: during the index encounter or within 30 days from the index procedure. Clinical experts agree these complications are still likely attributable to the hospital performing the procedure during this period and rates for these complications remained elevated until roughly 30 days post procedure.
- Mechanical complications and periprosthetic joint infection/wound infection: during the index encounter or within 90 days of the index procedure. Experts agree that mechanical complications and periprosthetic joint infection/wound infections due to the index THA/TKA occur up to 90 days following the index encounter.
The detailed list of the complication diagnosis and procedure codes (ICD-10-CM and ICD-10 PCS) is provided in the Data Dictionary Table 6. HKComp Outcome Inclusion.
Denominator
To be included in the measure denominator, patients must meet the following inclusion criteria:
- Enrolled in Medicare FFS Part A and Part B for the 12 months prior to and including the date of the encounter.
- Aged 65 or older.
- Have a qualifying elective primary THA/TKA procedure in an inpatient or outpatient department of a non-federal, short-term, acute care hospital, or in a free-standing ASC.
Elective qualifying primary THA/TKA procedures are defined as those procedures WITHOUT any of the following:
• Fracture of the pelvis or lower limbs coded as Present on Admission (POA) in the principal or secondary discharge diagnosis fields on the index encounter.
This criterion is not applicable to periprosthetic fractures for procedures performed in the outpatient setting.
• A concurrent partial hip or knee arthroplasty procedure.
• A concurrent revision, resurfacing, or implanted device/prosthesis removal procedure.
• Mechanical complication coded in the principal discharge diagnosis field on the index encounter.
• Malignant neoplasm of the pelvis, sacrum, coccyx, lower limbs, or bone/bone marrow, or a disseminated malignant neoplasm coded in the principal discharge diagnosis field on the index encounter.
• Transfer from another acute care facility for the THA/TKA.
• For outpatient procedures only: Healthcare Common Procedure Coding System (HCPCS) modifiers indicating discontinued procedures.
To be included in the measure cohort, patients must meet the following inclusion criteria:
- Enrolled in Medicare Fee-for-Service (FFS) Part A and Part B for the 12 months prior to and including the date of the encounter.
- Aged 65 or older.
- Have a qualifying elective primary THA/TKA procedure in an inpatient or outpatient department of a non-federal, short-term, acute care hospital, or in a free-standing ASC. A detailed list of the qualifying elective primary THA/TKA procedure codes (ICD-10 PCS) is provided in the Data Dictionary Table 1. HKComp Cohort Inclusions.
Elective qualifying primary THA/TKA procedures are defined as those procedures WITHOUT any of the following:
- Fracture of the pelvis or lower limbs coded as Present on Admission (POA) in the principal or secondary discharge diagnosis fields on the index encounter.
- The POA criterion is only applicable in the inpatient setting.
- A concurrent partial hip or knee arthroplasty procedure.
- A concurrent revision, resurfacing, or implanted device/prosthesis removal procedure.
- Mechanical complication coded in the principal discharge diagnosis field on the index encounter.
- Malignant neoplasm of the pelvis, sacrum, coccyx, lower limbs, or bone/bone marrow, or a disseminated malignant neoplasm coded in the principal discharge diagnosis field on the index encounter.
- Transfer from another acute care facility for the THA/TKA.
- For outpatient procedures only: Healthcare Common Procedure Coding System (HCPCS) modifiers indicating discontinued procedures.
A detailed list of the diagnostic and procedure codes (ICD-10 CM and ICD-10 PCS) that do not qualify for the denominator and hence are not included in the measure cohort is provided in the Data Dictionary Table 2. HKComp Cohort Exclusions.
Exclusions
After applying the above criteria to the admissions to identify eligible elective primary THA/TKA procedures, the measure excludes procedures for patients:
- Without at least 90 days post-discharge enrollment in Medicare Fee-for-Service (FFS) or Medicare Advantage (MA);
- Discharged against medical advice (AMA);
- With more than two THA/TKA procedure codes during the index procedure; and,
- With a principal diagnosis code of COVID-19 (ICD-10-CM code U07.1) or with a secondary diagnosis code of COVID-19 coded as present on admission on the index claim.*
All denominator exclusions are displayed in Figure 1. THA/TKA Complications Measure for ECs and EC Groups: Index Cohort in the All Tables and Figures attachment.
*This exclusion will be removed when the measure is implemented.
- Without at least 90 days post-discharge enrollment in Medicare Fee-for-Service (FFS) and/or Medicare Advantage (MA);
- Rationale: The 90-day complication outcome cannot be assessed in this group since claims data are used to determine whether a complication of care occurred.
- Discharged against medical advice (AMA);
- Rationale: Clinicians did not have the opportunity to deliver full care and prepare the patient for discharge.
- With more than two THA/TKA procedure codes during the index hospitalization; and,
- Rationale: Although clinically possible, it is highly unlikely that patients would receive more than two elective THA/TKA procedures in one encounter. Coding in such cases may reflect a coding error.
- With a principal diagnosis code of COVID-19 (ICD-10-CM code U07.1) or with a secondary diagnosis code of COVID-19 coded as POA on the index admission claim.
- Rationale: COVID-19 patients were removed from the THA/TKA cohort in response to the COVID-19 public health emergency (PHE). As noted above this criterion was part of the testing data but will be removed upon implementation. This is because clinicians and hospitals would have had adequate time to adjust to the presence of COVID-19 as an ongoing virus and it will allow for the inclusion of COVID-19 patients in the measure denominator to account for complete complication rates. We do not anticipate any meaningful change in performance with the removal of this exclusion.
After the above exclusions are applied, the measure randomly selects one index admission per patient per time period for inclusion in the cohort so that each episode of care is mutually independent with the same probability of the outcome. Additional admissions within that time period are excluded. Finally, the measure excludes procedures that are not attributable to an eligible clinician since only patients with adequate clinician claim for attribution should be included in the risk-adjustment model and the measure.
Measure Calculation
The Risk-Standardized Complications Rate (RSCR) is calculated as the ratio of the number of “predicted” (numerator) to the number of “expected” (denominator) outcomes for a given entity, multiplied by the national observed complication rate. For detailed information on measure outcomes, please refer to section 1.14.
We used Medicare administrative claims data and enrollment information for patients with qualifying procedures between April 1, 2019, and March 31, 2022. For detailed information on qualifying procedures and the index cohort, please see section 1.15.
The measure estimates Eligible Clinician (EC)/EC group-level RSCRs following elective primary THA/TKA using a hierarchical logistic regression model. We have defined ECs as unique combinations of National Provider Identifiers (NPIs) and Taxpayer Identification Numbers (TINs). Each attribution rule includes an algorithm for identifying a unique TIN/NPI combination. The unique TIN/NPI combinations that can be directly aggregated into groups with the same TIN are defined as EC groups.
In brief, the approach simultaneously models data at the patient and EC/EC group levels to account for variance in patient outcomes within and between entities (Normand and Shahian, 2007). At the patient level, the approach models the log odds of a complication using age, sex, selected clinical covariates, and an entity-specific intercept. At the EC/EC group level, it models the entity-specific intercepts as arising from a normal distribution. The entity-specific intercept represents the underlying risk of a complication attributed to the EC/EC group, after accounting for patient risk. The entity-specific intercepts are given a distribution to account for the clustering (non-independence) of patients within the entity. If there were no differences among entities, then after adjusting for patient risk, the entity intercepts should be identical across all entities.
For each entity, the predicted outcome (numerator) is the number of encounters with complications within the specified time period (up to 90 days) predicted based on the entity’s performance with its observed case mix. It is calculated by using the coefficients estimated by regressing the risk factors and the group-specific effect on the risk of having a complication. The estimated provider-specific effect is added to the sum of the estimated regression coefficients multiplied by the patient characteristics. The results are log-transformed and summed over all patients attributed to an entity to calculate a predicted value.
The expected outcome (denominator) is the number of encounters with complications expected based on the nation’s performance with that entity’s case mix. The expected number of encounters with a complication is obtained in the same manner as the predicted value, but a common effect using all entities in our sample is used in place of the provider-specific effect. The results are log-transformed and summed over all patients attributed to the entity to get an expected value.
To summarize, for each clinician, the numerator of the ratio is the number of complications predicted on the basis of the clinician’s performance with its observed case mix, and the denominator is the number of complications expected based on the nation’s performance with that clinician’s case mix. This approach is analogous to a ratio of “observed” to “expected” used in other types of statistical analyses. It conceptually allows for a comparison of a particular clinician’s performance given its case mix to an average clinician’s performance with the same case mix. Thus, a lower ratio indicates lower-than-expected complication rates or better quality, and a higher ratio indicates higher-than-expected complication rates or worse quality. This calculation transforms the ratio of predicted over expected into a rate that is compared to the national observed complication rate. The hierarchical logistic regression models are described fully in the in the All Tables and Figures attachment in Table 8. Hierarchical modeling - Model variable adjusted ORs.
The measure is risk-adjusted to account for patients’ characteristics such as age and gender, and factors that are clinically relevant and have strong relationships with the outcome. The measure adjusts for the procedure (THA or TKA), number of procedures (one or two), and the clinical setting where the procedure was performed (inpatient, outpatient, or ASC). Conditions that may represent adverse outcomes due to care received during the index procedure are not considered for inclusion in the risk adjustment. Although they may increase the risk of mortality and complications, including them as covariates in risk adjustment could attenuate the measure’s ability to characterize the quality of care delivered by the setting. The condition variables are obtained from inpatient, outpatient, and physician Medicare administrative claims data during the index procedure and extending 12 months prior.
For details on the risk adjustment variables, please refer to the Data Dictionary Table 3. HKComp All Risk Variables and Table 4. HKComp RVs Defined by ICD10s.
References
Normand S-LT, Shahian DM. 2007. Statistical and Clinical Aspects of Hospital Outcomes Profiling. Stat Sci 22(2): 206-226.
This measure is not stratified.
The measure does not have a minimum sample size.
Supplemental Attachment
Point of Contact
Not Applicable
Raquel Myers
Windsor Mill, MD
United States
Smitha Vellanky
Yale/YNHH Center for Outcomes Research and Evaluation (CORE)
New Haven, CT
United States
Importance
Evidence
Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA) procedures are among the most commonly performed orthopedic surgeries worldwide aimed at relieving pain and restoring function in patients with severe arthritis and joint damage. According to the American Academy of Orthopedic Surgeons (AAOS), between 2012 and 2022 more than 1.6 million TKAs and over 1 million THAs were performed in the United States (American Association of Orthopaedic Surgeons, 2023). Based on 2000‐to‐2014 data, one study predicted that annual THA volumes are projected to grow to 635,000 procedures a year by 2030 and TKA volumes to 1.26 million procedures a year by 2030 (Shichman et al., 2023; Sloan et al., 2018).
Although serious complications following elective THA and TKA are not common, they are measurable, modifiable, and vary in prevalence across clinicians. Periprosthetic joint infections can range from 0.2% to 2% in THA and TKA (Bourget-Murray et al., 2021; Bozic et al., 2014; Kurtz et al., 2018). Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is reported to occur in about 0.6% to 3.0% of THA and TKA patients (Simon et al., 2023). Reported 90-day death rates after THA or TKA were 0.65% (95% confidence interval (CI) 0.50 to 0.81) and 0.39% (95% CI 0.32 to 0.49), respectively (Berstock et al., 2014; Berstock et al., 2018). Rates for septicemia range from 0.1% during the index admission to 0.3% during the 90 days following discharge for primary TKA (Bozic et al., 2014).
Since THAs and TKAs are commonly performed and costly procedures, it is imperative to address quality of care to improve complication rates. There is evidence that complications following a THA/TKA procedure can be impacted by improvements in critical aspects of care, such as communication between clinicians, rapid response to complications, a focus on patient safety, and coordinated transitions to the outpatient environment (Bozic et al., 2014; Kurtz et al., 2018). Several studies indicate that by implementing quality improvement efforts, including multidisciplinary care teams, pre‐ and post‐counseling and education around THA/TKA procedures, and shared decision‐making, clinicians can reduce complications and overall associated costs (Kulshrestha et al., 2022; Sorensen et al., 2019; Wong et al., 2022).
In recent years there has been a steady increase in the number of elective THA and TKA procedures performed across outpatient surgical and ambulatory surgical center locations (Xu et al., 2019; Aynardi et al., 2014; Arshi et al., 2019; Bert et al., 2017; Goyal et al., 2017; Darrith et al., 2019; Migliorini et al., 2021; Mariorenzi et al., 2020). The shift in procedure setting coincides with the increase in demand for THA/TKA procedures (Triche et al., 2020; Wallace et al., 2025), necessitating the creation of quality measures that consider outcomes across all settings. The re-specified MIPS measure aligns with current care delivery system and will work well in cross-setting programs such as CMS’s Quality Payment Program to improve care quality.
References
American Association of Orthopaedic Surgeons. American Academy of Orthopaedic Surgeons 2023 Annual Report. In https://issuu.com/aaos1/docs/aaos_2023_annual_report?fr=sMDJhYjcwNjgyMTI
Arshi, A., et al., Outpatient total hip arthroplasty in the United States: A population-based comparative analysis of complication rates. J Am Acad Orthop Surg, 2019. 27(2): p. 61-67.
Aynardi, M., et al., Outpatient surgery as a means of cost reduction in total hip arthroplasty: A case-control study. HSS J, 2014. 10(3): p. 252-5.
Berstock, J. R., Beswick, A. D., Lenguerrand, E., Whitehouse, M. R., & Blom, A. W. (2014). Mortality after total hip replacement surgery: A systematic review. Bone & Joint Research, 3(6), 175-182. https://doi.org/10.1302/2046-3758.36.2000288
Berstock, J. R., Beswick, A. D., López-López, J. A., Whitehouse, M. R., & Blom, A. W. (2018). Mortality after total knee arthroplasty: A systematic review of incidence, temporal trends, and risk factors. The Journal of Bone and Joint Surgery. American Volume, 100(12), 1064-1070. https://doi.org/10.2106/JBJS.17.00630
Bert, J.M., J. Hooper, and S. Moen, Outpatient Total Joint Arthroplasty. Curr Rev Musculoskelet Med, 2017. 10(4): p. 567-574.
Bourget-Murray, J., Bansal, R., Soroceanu, A., Piroozfar, S., Railton, P., Johnston, K., ... & Powell, J. (2021). Assessment of risk factors for early-onset deep surgical site infection following primary total hip arthroplasty for osteoarthritis. Journal of Bone and Joint Infection, 6(9), 443-450.
Bozic KJ, Grosso LM, Lin Z, et al. Variation in hospital‐level risk‐standardized complication rates following elective primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2014;96(8):640‐647. doi:10.2106/JBJS.L.01639.
Darrith, B., et al., Inpatient Versus Outpatient Arthroplasty: A Single-Surgeon, Matched Cohort Analysis of 90-Day Complications. J Arthroplasty, 2019. 34(2): p. 221-227.
Goyal, N., et al., Otto Aufranc Award: A Multicenter, Randomized Study of Outpatient versus Inpatient Total Hip Arthroplasty. Clin Orthop Relat Res, 2017. 475(2): p. 364-372.
Kulshrestha, V., Sood, M., Kumar, S., Sood, N., Kumar, P., & Padhi, P. P. (2022). Does risk mitigation reduce 90‐day complications in patients undergoing total knee arthroplasty?: A cohort study. Clinics in Orthopedic Surgery, 14(1), 56.
Kurtz, S. M., Lau, E. C., Son, M. S., Chang, E. T., Zimmerli, W., & Parvizi, J. (2018). Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population. The Journal of arthroplasty, 33(10), 3238‐3245.
Mariorenzi, M., et al., Outpatient Total Joint Arthroplasty: A Review of the Current Stance and Future Direction. R I Med J (2013), 2020. 103(3): p. 63-67.
Migliorini F, C.L., Cuozzo F, Oliva F, Valerio Marino A, Maffulli N, Outpatient Total Hip Arthroplasty: A Meta-Analysis. Applied Sciences, 2021. 11(15): p. 6853-6864.
Shichman I, Roof M, Askew N, Nherera L, Rozell JC, Seyler TM, Schwarzkopf R. Projections and Epidemiology of Primary Hip and Knee Arthroplasty in Medicare Patients to 2040-2060. JB JS Open Access. 2023 Feb 28;8(1):e22.00112. doi: 10.2106/JBJS.OA.22.00112. PMID: 36864906; PMCID: PMC9974080.
Simon, S. J., Patell, R., Zwicker, J. I., Kazi, D. S., & Hollenbeck, B. L. (2023). Venous thromboembolism in total hip and total knee arthroplasty. JAMA Network Open, 6(12), e2345883-e2345883.
Sloan, M., Premkumar, A., & Sheth, N. P. (2018). Projected volume of primary total joint arthroplasty in the US, 2014 to 2030. JBJS, 100(17), 1455-1460
Sorensen, L., Idemoto, L., Streifel, J., Williams, B., Mecklenburg, R., & Blackmore, C. (2019). A multifaceted intervention to improve the quality of care for patients undergoing total joint arthroplasty. BMJ open quality, 8(3), e000664.
Triche, E., J.N. Grady, and J.e.a. Debuhr, Procedure Specific Complication Measure Updates and Specifications Report: Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) Risk-Standardized Complication Measure (Version 9.0). 2020.
Wallace LR, Tan Z, Barthel A, Sáenz MP, Grady JN, Balestracci KMB, Bozic KJ, Myers R, McDonough DL, Lin Z, Suter LG. Testing the Feasibility of a Cross-Setting Measure to Address the Rising Trend in Hospital Outpatient TJA Procedures. J Bone Joint Surg Am. 2025 Mar 19;107(6):604-613. doi: 10.2106/JBJS.23.01395. Epub 2024 Dec 5.
Wong, W., Bridges, C., Serebin, M., Gordon, A., Jones, S., Ebert, T., & Scheidt, K. (2022). A quality improvement project to decrease length of Stay after total hip and total knee arthroplasty surgery at a veteran affairs academic medical center. Perioperative Care and Operating Room Management, 26, 100230
Xu, J., et al., Comparison of outpatient versus inpatient total hip and knee arthroplasty: A systematic review and meta-analysis of complications. Journal of Orthopaedics, 2019. 17: p. 38-43.
Measure Impact
Measuring and reporting complication rates to inform patients and clinicians can help improve care, strengthen incentives for quality improvement, and improve the quality of care received and outcomes experienced by Medicare patients. As many clinicians may not be monitoring their patients’ complications after surgery, they may underestimate adverse events, suggesting the need for measurement to drive quality improvement. Clinicians, particularly the surgeons performing THA/TKA procedures, can influence the outcome of the surgeries, both through their technical skill and through their influence on the care team and hospital safety culture (Odell et al., 2019; Aveling et al, 2018; Andereggen et al., 2022; Woods et al., 2023). Therefore, many of the strategies and best practices used by the best performing clinicians to reduce the risk of complications can also be adopted by other individual clinicians and groups of clinicians to improve patient outcomes. Further evidence of surgeons’ influence includes data indicating that increasing surgeons’ volume is associated with reductions in adverse surgical outcomes (Battaglia et al., 2006; Shervin, et al., 2007). With THA/TKA procedures becoming increasingly common, a measure for clinicians to monitor THA/TKA complications could further support the positive effect of increased surgeons’ volume. For THA and TKA procedures, most patients have sufficient time to consider their options and understand the quality differences between clinicians. Therefore, both patients and clinicians can benefit from this outcome measure – a broad, patient‐centered outcome that reflects procedure‐specific complications among patients undergoing THA/TKA in various settings (Wallace et al., 2025).
Complications following THA/TKA surgery have been shown to impact broader patient outcomes such as quality of life. For example, a 2019 study found that patients who experience postoperative complications were more likely to report lower quality of life in comparison to patients who did not experience complications, and the magnitude of the impact was similar across variables such as increased age and the presence of comorbidities (Woodfield et al., 2019). The relationship between post‐surgical complications and reduced quality of life has been confirmed in multiple more recent studies (Shichman et al., 2023; Iliopoulou-Kosmadaki et al., 2023). Importantly, individuals typically undergo elective THA/TKA procedures to improve their quality of life; however, for patients with complications after TKA, complications have been shown to be significantly associated with lower quality of life (Askari et al., 2024).
Measurement of patient outcomes allows for a comprehensive view of the quality of care that reflects complex aspects of care such as communication between clinicians and coordinated transitions to the outpatient environment. Furthermore, providing outcome rates to clinicians makes visible meaningful quality differences and incentivizes improvement. These assessments are critical to patient outcomes and are broader than what can be captured by individual process of care measures. The respecified THA/TKA Complications measure for ECs and EC Groups across all settings is intended to inform quality-of-care improvement efforts. There is a simultaneous increase in demand for THA and TKA procedures and a shift in these procedures from the inpatient-only setting to hospital outpatient departments as well as Ambulatory Surgery Centers (ASC) for Medicare patients. By expanding the cohort and outcome of the existing inpatient-only measure to include outpatient and ASC settings, the respecified THA/TKA Complications measure for ECs and EC Groups has the potential to better illuminate differences in quality across settings, drive quality improvement, and enhance care coordination for elective THA and TKA procedures conducted in any setting. It complements the inpatient-only hospital measure as a proportion of surgeons have very different performance quality than the institutions in which they perform surgery. While the hospital-level measure assesses institutions’ performance in managing postoperative care and complications, the clinician-level measure allows for evaluation of specific clinicians’ performance with respect to complications after THA/TKA.
References
Andereggen, L., Andereggen, S., Bello, C., Urman, R. D., & Luedi, M. M. (2022). Technical skills in the operating room: Implications for perioperative leadership and patient outcomes. Best Practice & Research Clinical Anaesthesiology, 36(2), 237–245. https://doi.org/10.1016/j.bpa.2022.05.002
Askari A, Mohammadpour M, Jabalameli M, Naeimipoor N, Goodarzy B, Jafari B, Rashidi H, Mousazadeh F, Rajei M, Khazanchin A, Bahardoust M, Hassanzadeh M. Predictors of health‐related quality of life after total knee arthroplasty: a case‐control study. Sci Rep. 2024 Jun 19;14(1):14176. doi: 10.1038/s41598‐024‐65042‐z. PMID: 38898136; PMCID: PMC11187171
Aveling EL, Stone J, Sundt T, Wright C, Gino F, Singer S. Factors Influencing Team Behaviors in Surgery: A Qualitative Study to Inform Teamwork Interventions. Ann Thorac Surg. 2018 Jul;106(1):115-120. doi: 10.1016/j.athoracsur.2017.12.045. Epub 2018 Feb 7. PMID: 29427618; PMCID: PMC6021556.
Battaglia TC, Mulhall KJ, Brown TE, Saleh KJ. Increased surgical volume is associated with lower THA dislocation rates. Clin Orthop Relat Res. 2006 Jun;447:28-33.
Iliopoulou-Kosmadaki S, Hadjimichael AC, Kaspiris A, Lianou I, Kalogridaki M, Trikoupis I, Touzopoulos P, Velivasakis E, Sperelakis I, Laskaratou ED, Melissaridi D, Vasiliadis E, Kontakis G, Papagelopoulos PJ, Savvidou OD. Impact of Preoperative Quality of Life and Related Factors on the Development of Surgical Site Infections Following Primary Total Joint Arthroplasty: A Prospective Case-Control Study with a Five-Year Follow-Up. Adv Orthop. 2023 Feb 2;2023:7010219. doi: 10.1155/2023/7010219. PMID: 36777623; PMCID: PMC9911246.
Odell DD, Quinn CM, Matulewicz RS, Johnson J, Engelhardt KE, Stulberg JJ, Yang AD, Holl JL, Bilimoria KY. Association Between Hospital Safety Culture and Surgical Outcomes in a Statewide Surgical Quality Improvement Collaborative. J Am Coll Surg. 2019 Aug;229(2):175-183. doi: 10.1016/j.jamcollsurg.2019.02.046. Epub 2019 Mar 9. PMID: 30862538; PMCID: PMC6661205.
Shervin N, Rubash HE, Katz JN. Orthopaedic procedure volume and patient outcomes: a systematic literature review. Clin OrthopRelat Res. 2007 Apr;457:35-41.
Shichman, I., Sobba W., Beaton, G., Polisetty, T., Nguyen, H.B., Dipane, M.V., Hayes, E., Aggarwal, V.K., Sassoon, A.A., Chen, A.F., Garceau, S.P., Schwarzkopf, R. The Effect of Prosthetic Joint Infection on Work Status and Quality of Life: A Multicenter, International Study. The Journal of Arthroplasty. 2023 Dec; 38(12), 2685-2690.e1. doi: 10.1016/j.arth.2023.06.015.
Wallace LR, Tan Z, Barthel A, Sáenz MP, Grady JN, Balestracci KMB, Bozic KJ, Myers R, McDonough DL, Lin Z, Suter LG. Testing the Feasibility of a Cross-Setting Measure to Address the Rising Trend in Hospital Outpatient TJA Procedures. J Bone Joint Surg Am. 2025 Mar 19;107(6):604-613. doi: 10.2106/JBJS.23.01395. Epub 2024 Dec 5. PMID: 39637009.
Woodfield J, Deo P, Davidson A, Chen TY, van Rij A. Patient reporting of complications after surgery: what impact does documenting postoperative problems from the perspective of the patient using telephone interview and postal questionnaires have on the identification of complications after surgery? BMJ Open. 2019 Jul 9;9(7):e028561. doi: 10.1136/bmjopen‐2018‐028561. PMID: 31289081; PMCID: PMC6615906.
Woods MS, Liberman JN, Rui P, Wiggins E, White J, Ramshaw B, Stulberg JJ. Association between Surgical Technical Skills and Clinical Outcomes: A Systematic Literature Review and Meta-Analysis. JSLS. 2023 Jan-Mar;27(1):e2022.00076. doi: 10.4293/JSLS.2022.00076. PMID: 36818767; PMCID: PMC9913064.
Performance Gap
Table 1 and Figures 2a and 2b (in the All Tables and Figures attachment) show that there is meaningful variation in the distribution of measure scores using April 1, 2019, through March 31, 2022, data. As shown in Table 1, Risk-Standardized Complications Rates (RSCRs) range from 0.98% to 10.44% with a median of 2.59% for Eligible Clinicians (ECs) and from 1.19% to 4.66% with a median of 2.62% for EC groups. For ECs, the 10th percentile is 2.07% and the 90th percentile is 3.42%. For EC groups, the 10th percentile is 2.19% and the 90th percentile is 3.20%. The best performing ECs (0.98%) has an RSCR that is 62.1% better than the median (2.59%); the worst performing ECs (10.44%) has an RSCR that is 303.1% worse than the median (2.59%). Within EC groups, the best performer (1.19%) is 54.6% better than the median (2.62%) while the worst performer (4.66%) is 77.9% worse than the median performer.
We provide further evidence of variation by calculating and interpreting the median odds ratio (Merlo, et al., 2006). The median odds ratio, in this context, calculates the odds of the outcome (complications) if the same patient were treated by a higher‐risk EC/EC group compared with a lower‐risk EC/EC group. The median odds ratio for the measure is 1.49 for ECs and 1.34 for EC groups. This indicates that a patient has 1.5 times the odds (or 50% greater risk) of a complication for an EC and 1.3 times the odds (or 30% greater risk) of a complication for an EC group if they were treated by a high‐risk ECs or EC group compared to a lower‐risk ECs or EC groups, respectively, indicating meaningful variation in performance.
Please see the All Tables and Figures Attachment Table 1. THA/TKA Complications Measure for ECs and EC Groups with at least 20 Cases: Distribution of THA/TKA Risk-standardized Complication Rates (RSCR).
See Table 2a. Performance Score by Decile for ECs and Table 2b. Performance Score by Decile for EC Groups in the All Tables and Figures attachment.
Reference
Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, Råstam L, Larsen K. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006 Apr;60(4):290-7. doi: 10.1136/jech.2004.029454. PMID: 16537344; PMCID: PMC2566165.
Overall | Minimum | Decile_1 | Decile_2 | Decile_3 | Decile_4 | Decile_5 | Decile_6 | Decile_7 | Decile_8 | Decile_9 | Decile_10 | Maximum | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean Performance Score | 2.67 | 1.19 | 2.07 | 2.38 | 2.51 | 2.58 | 2.62 | 2.64 | 2.71 | 2.82 | 2.98 | 3.41 | 4.66 |
N of Entities | 4,604 | 1 | 460 | 460 | 461 | 460 | 461 | 460 | 461 | 460 | 461 | 460 | 1 |
N of Persons / Encounters / Episodes | 980,197 | 1,700 | 305,713 | 155,689 | 85,070 | 51,090 | 27,394 | 10,432 | 84,029 | 55,089 | 95,444 | 110,247 | 169 |
Equity
Equity
This domain is optional for Spring 2025.
Feasibility
Feasibility
This is a claims-based measure, and all data elements are in structured fields that are available in electronic sources.
CMS monitors feedback from the public and measured entities and there have been no concerns about feasibility or burden related to the currently implemented version of this measure and hence, we expect no new concerns regarding the respecified measure. There are no concerns about patient confidentiality because the measure is based on claims data submitted by facilities to CMS, and CMS then uses that data for both payment and calculation of the measure score.
We did not perform an analysis of missing data for the measure because it is based on a 100% sample of paid, final action claims submitted by facilities for payment.
The changes made to the measure during re-specification do not impact data availability or burden considerations.
There are no costs or other burdens for this measure (for any component, including the calculation of the score) because the measure score is calculated (by CMS) automatically from claims data which are routinely generated during the delivery of care. This measure does not require additional data collection by Eligible Clinicians (ECs)/EC groups, which eliminates any reporting burden.
Because the measure’s data are automatically generated during patient care, and because CMS calculates and reports the data, there is no impact on clinician workflow (e.g., modifications), diagnostic thought processes, or patient-physician interaction. There are no barriers to implementing the measure specifications, including data collection and measure calculation, and no barriers to performance reporting.
There are no concerns about patient confidentiality because the measure is based on claims data submitted by Eligible Clinicians (ECs)/EC groups to CMS, and CMS uses that data for both reimbursement and calculation of the measure score.
Because this is a claims-based measure there is no burden on the facility or its clinicians and no feasibility concerns; rates are automatically calculated by CMS based on claims data submitted by facilities for payment.
Proprietary Information
Scientific Acceptability
Testing Data
We used Medicare administrative claims data and enrollment information for patients with qualifying procedures between April 1, 2019, and March 31, 2022, extending through June 30, 2022, for the capture of complications. For details on data sources, refer to section 1.25 Data Source Details.
None
The THA/TKA complication measure for Eligible Clinicians (ECs) and EC Groups attributes outcomes for each patient in the cohort to a single clinician or a group of clinicians. Conceptually, this is the ECs or EC group with the primary responsibility for the procedure and procedure‐related care.
We have defined ECs as unique combinations of Taxpayer Identification Numbers (TINs) and National Provider Identifiers (NPIs). Each attribution rule includes an algorithm for identifying a unique TIN/NPI combination (see Section 2.5 in Measure Reevaluation report attachment for details on approach to attribution).
The unique TIN/NPI combinations that can be directly aggregated into groups with the same TIN are defined as EC groups. Note that patients can only be assigned to groups by way of an EC (a unique TIN/NPI combination), and thus these are by default groups with at least one EC. Within the Merit-based Inceptive Payment System (MIPS), where this measure is currently implemented, an EC “group” must include two or more ECs, at least one of which participates in MIPS.
The number ECs and EC groups included in the measure with the performance period of April 1, 2019, to March 31, 2022, is in Table 4. Procedure volume for ECs and EC groups can be found in the All Tables and Figures attachment.
After applying the inclusions and exclusions to the cohort and attributing patients to ECs and EC groups the population size was N= 980,197 encounters. See Table 5. Characteristics of the Eligible Population in the All Tables and Figures attachment.
Reliability
To ascertain measure score reliability, we calculated the intra-class correlation coefficient (ICC) using a split-sample (also known as the split-half) method using three years of data (April 1, 2019-March 31,2022). We calculated the ICC as the average over 100 iterations of resampling without replacement, described in more detail below.
The reliability of a measurement is the degree to which repeated measurements of the same entity agree with each other. For measures of Eligible Clinicians (ECs)/EC group performance, the measured entity is the EC/EC group, and reliability is the extent to which repeated measurements of the same EC/EC group give similar results. Accordingly, our approach to assessing reliability is to consider the extent to which assessments of an EC/EC group using different but randomly selected subsets of patients produce similar measures of EC/EC group performance. EC/EC group performance is measured once using a random subset of patients (within an EC/EC group) from a defined dataset from a measurement period and then measured again using a second random subset of patients exclusive of the first from the same measurement period, and the agreement of the two resulting performance measures are compared across ECs/EC groups (Rousson et al., 2002). To the extent that the calculated measures of these two subsets agree, we have evidence that the measure is assessing an attribute of the EC/EC group, not of the patients. Recent research by Nieser and Harris (2024) shows that averaging multiple split-sample reliability estimates yields a more stable result (referred as permutation split sample reliability), so we adopted this approach to the reliability testing for this measure.
Specifically, for the testing of the THA/TKA Complications measure, using three years of data (April 1, 2019-March 31, 2022) we randomly sampled half of patients for each EC/EC group, calculated the measure score for each EC/EC group, and repeated the calculation using the second half of patients. Thus, each EC/EC group is measured twice, but each measurement is made using an entirely distinct set of patients. We repeated this process, randomly sampling the data 100 times without replacement, and, as a metric of agreement, we calculated the average ICC across all 100 samples (Shrout and Fleiss, 1979; Nieser and Harris, 2024). The agreement of the two measure scores was quantified for ECs/EC groups in each sample using the ICC as defined by ICC (2,1) (Shrout and Fleiss, 1979), and a correction using the Spearman-Brown prophecy formula was performed (Brown, 1920; Spearman, 1910). We calculated split-half reliability for all ECs/EC groups for ECs/EC groups with at least 20 admissions, the reporting threshold.
References
Brown, W. (1910). “Some experimental results in the correlation of mental abilities.” British Journal of Psychology 1904-1920, 3(3), 296–322. https://doi.org/10.1111/j.2044-8295.1910.tb00207.x
Nieser and Harris. “Split-sample reliability estimation in health care quality measurement: Once is not enough.” Health Serv Res. 2024;59:e14310.
Rousson V, Gasser T, Seifert B. "Assessing intrarater, interrater and test–retest reliability of continuous measurements," Statistics in Medicine, 2002, 21:3431-3446.
Shrout P, Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychological Bulletin, 1979, 86, 420-3428.
Spearman, C. (1910). “Correlation calculated from faulty data.” British Journal of Psychology 1904-1920, 3(3), 271–295. https://doi.org/10.1111/j.2044-8295.1910.tb00206.x
Eligible Clinicians (ECs)
For ECs with at least 20 admissions, the average ICC (mean across 100 random samples) was 0.598.
Eligible Clinician (EC) groups
For EC groups with at least 20 admissions, the average ICC (mean across 100 random samples) was 0.802.
Our results show that measure score reliability for this measure, for both ECs and EC groups, meets the consensus-based entity (CBE) endorsement threshold (minimum ≥0.6) meaning that this measure is sufficiently reliable for public reporting, for ECs/EC groups with at least 20 admissions.
Validity
Validity of Claims-Based Variables
During original measure development, we assessed the validity of claims-based variables to identify complications through a medical record validation study. The primary goal of the validation study was to determine the overall agreement between patients identified as having a complication (or no complication) in the claims-based measure and those who had a complication (or no complication) also documented in the medical record. We conducted a secondary analysis of agreement of individual specific complications to identify opportunities for measure improvement. This study is described in more detail in the original measure development methodology report, located at this URL: https://qualitynet.cms.gov/files/5d0d369b764be766b010080b?filename=DryRun_HK_C_TechReport_081012%2C0.pdf
Measure Validity
Construct Validity
To evaluate the validity of the THA/TKA Complications measure for ECs and EC Groups and demonstrate known-groups validity, which is a form of construct validity, we assessed the measure score’s correlation with the quality construct of volume.
Volume may be considered a quality construct in that it is a proxy for underlying quality-related factors. Clinicians with higher operative volume for THA/TKA procedures may have greater experience and repeated performance of evidence-based processes, allowing for the development and implementation of standardized care delivery, which in turn can reduce errors and delays in care and improve outcomes.
There is evidence that surgical complication rates for providers (both surgeons and hospitals) decline with increasing THA and TKA volume (Sibley et al., 2017; Murphy et al., 2019; Courtney et al., 2018). Thus, we assessed the validity of the THA/TKA Complications measure for ECs and EC Groups by examining the relationship between volume and the measure score for ECs and EC groups. To establish validity, we expected THA/TKA measure scores to be correlated with EC/EC group case volume. We hypothesized that there would be a weak to moderate, negative relationship between clinician volume and clinician-level measure scores, with higher volumes associated with better (lower) clinician-level measure scores.
These concepts are discussed in Section 2.2 and Section 6.2.1 and are shown in the logic model (Table 3 in the All Tables and Figures attachment).
Face Validity
The clinician-level measure (THA/TKA Complications measure for ECs and EC Groups) is in part, a re-specification of a hospital-based measure (Hospital-level 90-Day Risk-Standardized Complication Rate (RSCR) Following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) for a Combined Inpatient (IP) and Outpatient (OP) Setting Measure [hereafter referred to as IP/OP 90-Day THA/TKA Complication Measure]), which included both inpatient and outpatient procedures, that was developed but not implemented. The two measures have the same specifications, other than their intended level of accountability. During the development of the hospital-based measure we assessed the IP/OP 90-Day THA/TKA Complications measure’s face validity with a technical expert panel (TEP) of national experts and stakeholder organizations.
The TEP was comprised of clinicians, health services researchers, patients, patient advocates/caregivers, health insurance representatives, and hospital administrators (see Table 6. IP/OP 90-Day THA/TKA Complication Measure: List of Technical Expert Panel (TEP) Members in the All Tables and Figures attachment for additional details on panel members).
We systematically assessed the face validity of the measure score as an indicator of quality by soliciting TEP members’ agreement with the following two statements using a six-point scale (1 = Strongly Agree, 2 = Moderately Agree, 3 = Somewhat Agree, 4 = Somewhat Disagree, 5 = Moderately Disagree, 6 = Strongly Disagree):
Statement #1: The THA/TKA Complication measure as specified will provide a valid assessment of complications following elective THA/TKA.
Statement #2: The THA/TKA Complication measure as specified can be used to distinguish between better and worse quality care among hospitals performing THAs/TKAs.
Although we did not evaluate face validity for the THA/TKA Complications measure for ECs and EC Groups measure, given these methods for assessing face validity, we believe the IP/OP 90-Day THA/TKA Complications measure’s face validity results applies to the corresponding clinician-level measure.
References
Courtney M, Frisch N, Bohl D, Della Valle C. Improving Value in Total Hip and Knee Arthroplasty: The Role of High Volume Hospitals. The Journal of Arthroplasty. 2018;33(1):1-5. https://doi.org/10.1016/j.arth.2017.07.040.
Hegde V, Stambough JB, Levine BR, Springer BD. Highlights of the 2022 American Joint Replacement Registry Annual Report. Arthroplast Today. 2023 Apr 25;21:101137.
Murphy WS, Cheng T, Lin B, Terry D, Murphy SB. Higher Volume Surgeons Have Lower Medicare Payments, Readmissions, and Mortality After THA. Clin Orthop Relat Res. 2019;477(2):334‐341. doi:10.1097/CORR.0000000000000370.
Sibley R, Charumbhumi, V, Hutzler L, Paoli A, Bosco, J. Joint Replacement Volume Positively Correlates With Improved Hospital Performance on Centers for Medicare and Medicaid Services Quality Metrics. The Journal of Arthroplasty. 2017;32(5):1409-1413. https://doi.org/10.1016/j.arth.2016.12.010.
Data Element Validity
Overall, measure agreement was 93% (598/644 patients). More specifically, there were 598 patients who either had a complication coded in the claims and a complication was also documented in the medical record or who had no complication documented in both claims and medical record data. When we examined overall agreement in patients with and without complications, the initial agreement was 86% for patients with a complication compared with 99% for patients without a complication. After making some changes to the measure during measure development (see details in the original methodology report here (https://qualitynet.cms.gov/files/5d0d369b764be766b010080b?filename=DryRun_HK_C_TechReport_081012%2C0.pdf) (which included adding an exclusion for removing mechanical complications from the index admission, as these were present-on-admission, and also removing a non-specific sepsis code), measure agreement between claims data and the medical record increased to 99% (635/644).
Construct Validity
Table 7 in the All Tables and Figures attachment shows mean measure scores for the THA/TKA Complications measure for ECs and EC Groups measure within deciles of procedural volume for both ECs and EC groups. As expected, and consistent with the literature, improvement in measure scores is seen at higher volumes. For example, mean measure scores for EC groups in the 5th volume decile were 2.75% compared with 2.41% for EC groups in the 10th volume decile. The correlation coefficient for the association between volume and clinician-level measure scores (RSCRs) was -0.214 for 8,562 ECs and -0.194 for 3,081 EC groups (for ECs/ EC groups with at least 20 procedures).
Face Validity
Below we describe the survey results for each statement related to the hospital-level IP/OP 90-Day THA/TKA Complications measure.
Twelve of 13 TEP members responded to the face validity survey.
Statement #1: The THA/TKA Complication measure as specified will provide a valid assessment of complications following elective THA/TKA.
Twelve of 12 responding TEP members (100%) agreed (strongly, moderately, somewhat) with the first face validity statement.
The specific counts for each voting category are shown below:
- Strongly agree: 5 (41.7%)
- Moderately agree: 6 (50%)
- Somewhat agree: 1 (8.3%)
- Somewhat disagree: 0 (0.0%)
- Moderately disagree: 0 (0.0%)
- Strongly disagree: 0 (0.0%)
- Strongly agree: 3 (25%)
- Moderately agree: 6 (50%)
- Somewhat agree: 3 (25%)
- Somewhat disagree: 0 (0.0%)
- Moderately disagree: 0 (0.0%)
- Strongly disagree: 0 (0.0%)
Statement #2: The THA/TKA Complication measure as specified can be used to distinguish between better and worse quality care among hospitals performing THAs/TKAs.
Twelve of 12 responding TEP members (100%) agreed (strongly, moderately, somewhat) with the second face validity statement.
The specific counts for each voting category are shown below:
- Strongly agree: 3 (25%)
- Moderately agree: 6 (50%)
- Somewhat agree: 3 (25%)
- Somewhat disagree: 0 (0.0%)
- Moderately disagree: 0 (0.0%)
- Strongly disagree: 0 (0.0%)
The validity of this measure is supported by four sources of evidence: (1) empiric validity testing supporting a volume/outcome relationship, (2) strong face validity, (3) evidence of improvement, and (4) evidence of data element validity from original measure development.
Our testing results show a volume-outcome relationship between ECs and EC groups’ procedural volume and the measure outcome, risk-standardized complication rates (RSCRs). As expected, the negative correlation coefficient and lower mean RSCR in higher deciles of volume indicate that there is a moderate but meaningful inverse volume-outcome relationship for both ECs and EC groups, meaning that higher volume is associated with better outcomes.
Higher surgeon volume has been shown to be associated with better patient outcomes for a range of surgical procedures, including THA and TKA. Specifically for THA and TKA, surgeon and hospital volume has been shown to influence key outcomes such as surgical complications, revision rates, and hospital readmissions (Kugler et al., 2022; Siddiqi et al., 2022). There are several potential mechanisms underlying this relationship. First, “practice makes perfect:” higher volume may result in surgeons gaining technical skills, including the use of more consistent operative techniques, fewer intraoperative errors, and more efficient handling of complications (Birkmeyer et al., 2013; Morche et al., 2016). High-volume surgeons may be more likely to follow evidence-based procedures and may be more likely to work in a health care setting (facility) that has developed standardized perioperative care pathways, contributing to lower complication and readmission rates (Bozic et al., 2010). Moreover, the experience curve hypothesis suggests that outcomes improve with cumulative experience (Zwart et al., 2023). Surgeon volume effects may be enhanced when combined with high hospital volume; higher volume hospitals, that may have more resources and/or dedicate more available resources to elective surgeries, may facilitate better care coordination and hospital/facility-based standardized procedures (such as those at discharge) (Pappas et al., 2022; Mufarrih et al., 2019). Finally, it is possible that physicians (and hospitals) that have better outcome rates obtain higher volumes through professional and patient self-referrals (when volumes and/or complication rates are publicly reported), through participating in insurance/employer networks of high performing facilities (Walmart Stores et al., 2018), or that other provider characteristics that drive referrals (reputation for example) serve as a proxy for volume (Finn et al., 2022).
The validity of this respecified THA/TKA Complications measure for EC and EC Groups is further supported by strong face validity results for a highly related measure (the same measure, but at the hospital level), with 100% agreement of face validity from the Technical Panel Experts (TEP).
In addition, analyses based on the current publicly reported hospital-level Fee-for-Service (FFS)-only THA/TKA Complications measure show that there has been improvement in measure scores over time (see Section 6.2.4) in a setting of quality improvement efforts (see Section 6.2.1).
Finally, data element validity testing performed during original measure development supports the validity of data elements that capture the complications that comprise the measure’s outcome.
References
Birkmeyer JD, Finks JF, O'Reilly A, Oerline M, Carlin AM, Nunn AR, Dimick J, Banerjee M, Birkmeyer NJ; Michigan Bariatric Surgery Collaborative. Surgical skill and complication rates after bariatric surgery. N Engl J Med. 2013 Oct 10;369(15):1434-42. doi: 10.1056/NEJMsa1300625. PMID: 24106936.
Bozic KJ, Maselli J, Pekow PS, Lindenauer PK, Vail TP, Auerbach AD. The influence of procedure volumes and standardization of care on quality and efficiency in total joint replacement surgery. J Bone Joint Surg Am. 2010 Nov 17;92(16):2643-52. doi: 10.2106/JBJS.I.01477. PMID: 21084575.
Finn CB, Tong JK, Alexander HE, Wirtalla C, Wachtel H, Guerra CE, Mehta SJ, Wender R, Kelz RR. How Referring Providers Choose Specialists for Their Patients: a Systematic Review. J Gen Intern Med. 2022 Oct;37(13):3444-3452. doi: 10.1007/s11606-022-07574-6. Epub 2022 Apr 19. PMID: 35441300; PMCID: PMC9550909.
Morche, J., Mathes, T. & Pieper, D. Relationship between surgeon volume and outcomes: a systematic review of systematic reviews. Syst Rev 5, 204 (2016). https://doi.org/10.1186/s13643-016-03764
Kugler, C.M., Goossen, K., Rombey, T. et al. Hospital volume–outcome relationship in total knee arthroplasty: a systematic review and dose–response meta-analysis. Knee Surg Sports Traumatol Arthrosc 30, 2862–2877 (2022). https://doi.org/10.1007/s00167-021-06692-8.
Mufarrih, S.H., Ghani, M.O.A., Martins, R.S. et al. Effect of hospital volume on outcomes of total hip arthroplasty: a systematic review and meta-analysis. J Orthop Surg Res 14, 468 (2019). https://doi.org/10.1186/s13018-019-1531-0.
Pappas, M.A., Spindler, K.A., Hu, B., Higuera-Rueda, C.A., Rothberg, M.B. Volume and Outcomes of Joint Arthroplasty. The Journal of Arthroplasty 37 (11), 2128-21 (2022). https://www.sciencedirect.com/science/article/pii/S0883540322005435.
Siddiqi A, Alamanda VK, Barrington JW, Chen AF, De A, Huddleston JI 3rd, Bozic KJ, Lewallen D, Piuzzi NS, Mullen K, Porter KR, Springer BD. Effects of Hospital and Surgeon Volume on Patient Outcomes After Total Joint Arthroplasty: Reported From the American Joint Replacement Registry. J Am Acad Orthop Surg. 2022 Jun 1;30(11):e811-e821. doi: 10.5435/JAAOS-D-21-00946. Epub 2022 Feb 21. PMID: 35191864.
Walmart Stores, Inc. (2018). Centers of Excellence for Spine Surgery [Case Study]. In Walmart Stores, Inc. https://www.catalyze.org/wp-content/uploads/woocommerce_uploads/2018/06/Walmart-Centers-of-Excellence_Case-Study_June-2018.pdf?utm_source=chatgpt.com
Zwart MJW, van den Broek B, de Graaf N, Suurmeijer JA, Augustinus S, Te Riele WW, van Santvoort HC, Hagendoorn J, Borel Rinkes IHM, van Dam JL, Takagi K, Tran KTC, Schreinemakers J, van der Schelling G, Wijsman JH, de Wilde RF, Festen S, Daams F, Luyer MD, de Hingh IHJT, Mieog JSD, Bonsing BA, Lips DJ, Abu Hilal M, Busch OR, Saint-Marc O, Zeh HJ 3rd, Zureikat AH, Hogg ME, Koerkamp BG, Molenaar IQ, Besselink MG; Dutch Pancreatic Cancer Group. The Feasibility, Proficiency, and Mastery Learning Curves in 635 Robotic Pancreatoduodenectomies Following a Multicenter Training Program: "Standing on the Shoulders of Giants". Ann Surg. 2023 Dec 1;278(6):e1232-e1241. doi: 10.1097/SLA.0000000000005928. Epub 2023 Jun 8. PMID: 37288547; PMCID: PMC10631507.
Risk Adjustment
Risk variables for this THA/TKA Complications measure for ECs and EC Groups were derived from the development of the original Hospital-level THA/TKA Complications measure (CBE #1550; FFS-only version). We describe the original selection of variables below.
Our goal in selecting risk factors for adjustment was to develop parsimonious models that included clinically relevant variables strongly associated with the risk of complication in the 90 days following an index procedure. We used a two-stage approach, first identifying the comorbidity or clinical status risk factors that were most important in predicting the outcome, then considering the potential addition of social risk factors.
The original Hospital-level THA/TKA Complications measure was developed with ICD-9. When ICD-10 became effective in 2015, we transitioned the measure to use ICD-10 codes as well. ICD-10 codes were identified using 2015 General Equivalence Mappings (GEM) mapping software. We then enlisted the help of clinicians with expertise in relevant areas to select and evaluate which ICD-10 codes map to the ICD-9 codes used to define this measure during development. A code set is attached in field 1.13a. (Data Dictionary).
For risk model development, we started with Condition Categories (CCs) which are part of CMS’s Hierarchical Condition Categories (HCCs). The HCC system groups the 70,000+ ICD-10-CM and 17,000+ ICD-9-CM codes into larger clinically coherent groups (201 CCs) that are used in models to predict mortality or other outcomes (Pope et al. 2001; 2011). The HCC system groups ICD codes into larger groups that are used in models to predict medical care utilization, mortality, or other related measures.
To select candidate variables, a team of clinicians reviewed all CCs and excluded those that were not relevant to the Medicare population or that were not clinically relevant to the complication outcome (for example, attention deficit disorder, female infertility). All potentially clinically relevant CCs were included as candidate variables and, consistent with CMS’s other claims-based measures, some of those CCs were then combined into clinically coherent CC groupings.
To inform final variable selection, a modified approach to stepwise logistic regression was performed. The Development Sample was used to create 1,000 “bootstrap” samples. For each sample, we ran a logistic stepwise regression that included the candidate variables. The results were summarized to show the percentage of times that each of the candidate variables was significantly associated with mortality (p<0.01) in each of the 1,000 repeated samples (for example, 90 percent would mean that the candidate variable was selected as significant at p<0.01 in 90 percent of the times). We also assessed the direction and magnitude of the regression coefficients.
The clinical team reviewed these results and decided to retain risk adjustment variables above a predetermined cutoff, because they demonstrated a strong and stable association with risk of complication and were clinically relevant. Additionally, specific variables with particular clinical relevance to the risk of complications were forced into the model (regardless of percent selection) to ensure appropriate risk adjustment for THA/TKA. These included variables representing markers for end of life/frailty, such as:
Markers for end of life/frailty:
- Decubitus Ulcer or Chronic Skin Ulcer (CC 157-CC 161)
- Metastatic and Other Major Cancers (CC 8-CC 12)
- Osteoporosis and Other Bone/Cartilage Disorders (CC 43)
- Chronic Kidney Disease, Stage 5 (CC 136)
- Hemiplegia, Paraplegia, Paralysis, Functional disability (CC 70-CC 74, CC 103, CC 104, CC 189-CC 190)
- Stroke (CC 99-CC 100)
This resulted in a final risk-adjustment model that included 33 variables.
Expanding the measure to include outpatient procedures
After developing the Hospital-level THA/TKA Complications measure for the hospital setting, the measure was re-specified (and CBE endorsed) for the EC/EC Group setting. Following that, the clinician-level measure was expanded to include procedures performed in inpatient and outpatient settings and was re-specified to include outcomes from outpatient settings. This expanded clinician-level THA/TKA Complications measure, with both inpatient and outpatient procedures (for cohort and outcomes) for ECs and EC Groups is the measure currently under consideration for CBE endorsement with this submission.
Because we expanded the THA/TKA Complications measure for ECs and EC Groups to include inpatient and outpatient procedures, we conducted exploratory analyses to examine the similarities and differences between the inpatient and outpatient cohorts with respect to risk factors used in the existing clinician-level measure, as well as basic non-clinical patient-level characteristics. The existing risk model includes several factors that are strong predictors of patient frailty and functional status, including malnutrition, osteoporosis and vertebral fractures, dementia, paralysis, and decubitus ulcers.
We examined risk‐adjustment variables for patients’ comorbid conditions identified in both inpatient and outpatient claims for the 12 months prior to the index encounter, as well as those coded as POA for patients in the inpatient cohort (Krumholz et al., 2019). Since POA indicators are not available in outpatient claims, for the outpatient cohort, conditions that may represent adverse outcomes due to care received during the index encounter are not adjusted for in the model.
Consistent with the currently implemented THA/TKA Complications measure for ECs and EC Groups, the final risk-adjustment model included 34 demographic and clinical comorbidity variables along with risk adjustment for the setting. As expected, the risk factor frequencies tend to be higher among patients in the inpatient setting when compared to outpatient and ASC settings, with a few exceptions.
This respecified clinician-level measure includes patients undergoing procedures in the inpatient, outpatient and ASC settings. Initial empiric analyses indicated that observed complication rates were lower after hospital outpatient/ASC procedures compared to inpatient procedures despite relatively modest differences in clinical risk factor frequency across settings. We concluded there are multiple factors influencing the decision to perform elective THA/TKA procedures in the inpatient versus outpatient setting. These factors include clinical risk assessment by the surgical team (including underlying patient frailty) hospital policies and resources, patient preference, and social determinants of health (SDOH) such as transportation, access to care, housing situation, home support, health literacy, and income (Silber et al., 2023). We defined the clinical setting as inpatient versus outpatient (observation stay or day surgery) or ASC using administrative encounter information.
To explore the influence of clinical setting on the risk model, we then assessed the model performance of a single combined model but with indicator variables added to reflect inpatient versus outpatient and ASC settings.
The odds of THA/TKA complications after surgery are significantly higher in the inpatient setting (OR, 1.39 (95% CI, 1.28, 1.51) and significantly lower in the hospital outpatient setting (OR, 0.90 (95% CI, 0.83, 0.98) compared to the ASC setting (the reference). Most risk factors are associated with higher odds of THA/TKA surgery complications except Other major cancers, Respiratory/heart/digestive/urinary/other neoplasms, and History of COVID.
Clinical and Social Risk Factor Conceptual Model
Although some recent literature evaluates the relationship between patient social risk factors and the complication outcome, few studies directly address causal pathways or examine the role of the hospital in these pathways.
The social risk factors that have been examined in the literature can be categorized into three domains: (1) patient-level variables, (2) neighborhood/community-level variables, and (3) hospital-level variables. Patient-level variables describe the characteristics of individual patients and include the patient’s race and ethnicity, income, or education level. For example, Black and Hispanic patients have been shown to experience higher rates of postoperative complications, longer lengths of stay, and more frequent non-home discharges (Rudisill et al., 2023; Usiskin and Misra, 2022; Brown, Paisner, and Sassoon, 2022)). These disparities are often influenced by socioeconomic factors such as lower income or education levels, which can limit access to healthcare services, preventive care, or rehabilitation (Alvarez et al., 2022). Additionally, barriers such as language proficiency or health literacy may further exacerbate these challenges and contribute to poorer outcomes and higher rates of complications for patients with social risk factors (Suleiman et al., 2021). Neighborhood/community-level variables use information from sources such as the American Community Survey (ACS) as either a proxy for individual patient-level data or to measure environmental factors. Studies using these variables use one-dimensional measures such as median household income or composite measures such as the Agency for Healthcare Research and Quality (AHRQ)-validated Socioeconomic Status (SES) index score (Blum et al., 2014; Courtney et al., 2016; Martsolf et al., 2016; White et al., 2018). Some of these variables may include the local availability of clinical providers (Herrin et al., 2015; Herrin et al., 2016). Hospital-level variables measure attributes of the hospital which may be related to patient risk. Examples of hospital-level variables used in studies are ZIP code characteristics aggregated to the hospital level, or the proportion of Medicaid patients served in the hospital (Gilman et al., 2014; Joynt et al., 2013; Jha et al., 2011; Xu et al., 2017).
The conceptual relationship, or potential causal pathways by which these possible social risk factors influence the risk of complication following an acute illness or major surgery, like the factors themselves, are varied and complex. There are at least four potential pathways that are important to consider:
- Comorbidities and social risk. Patients who have lower income/education/literacy or unstable housing may have a worse general health status and may present for their hospitalization or procedure with a greater severity of underlying illness. These social risk factors, which are characterized by patient-level or neighborhood/community-level (as proxy for patient-level) variables, may contribute to worse health status at admission due to competing priorities (for example, restrictions based on job), lack of access to care (e.g., geographic, cultural, or financial), or lack of health insurance. Given that these risk factors all lead to worse general health status, this causal pathway should be largely accounted for by current clinical risk adjustment. We note that empirically, patient comorbidities and social risk factors overlap in their contribution to higher risk of the outcome, as shown by our empirical evidence (see Section 5.3) demonstrating the attenuating impact of model variables on the odds ratios for each social risk factor (ADI; DE).
- Differential care. A second pathway by which social risk factors may contribute to complications risk is that patients may not receive equivalent care within a facility. For example, patients with social risk factors such as lower education may require differentiated care (e.g. provision of lower literacy information – that they do not receive).
- Low-quality hospitals. Patients with social risk factors may receive care at lower quality hospitals. Patients of lower income, lower education, or unstable housing may not have the same access to high quality facilities, in part, because such facilities may be less likely to be found in geographic areas with large populations of patients with social risk factors (Fahrenbach et. al., 2020). Thus, patients with low income may be more likely to be treated in lower quality hospitals, which may contribute to an increased risk of post-operative complications/readmission. In addition, or alternatively, low-quality hospitals may not implement the evidence-based interventions to reduce the risk of readmission, such as post-discharge follow up; patients with social risk factors are known to have lower rates of follow up after discharge and higher rates of post-discharge acute care.
- Residual risk. Some social risk factors, such as income or wealth, may affect the likelihood of complications without directly affecting health status at admission or the quality of care received during the hospital stay. For instance, while a hospital may make appropriate care decisions and provide tailored care and education, a lower-income patient may have a worse outcome post-discharge due to competing financial priorities that don’t allow for adequate recuperation or access to needed treatments, or a lack of access to care outside of the hospital.
Based on our previous work to identify social risk factors (“Additional Testing of Gaps in Mortality/Complication Measure Score Performance Among Selected Subpopulations of Interest Defined by Social Risk Factor (SRF) for the 2024 MUC Submissions,” 2024), the social risk factors used for the additional testing and the rationale were:
- Dual eligible (DE) status: DE status (i.e., enrolled in both Medicare and Medicaid) for a discharge is derived using the beneficiary enrollment data file in the Integrated Data Repository (IDR). The data includes monthly enrollment status, and a patient is considered DE for an index admission if they are enrolled in both Medicare and Medicaid in the month of discharge date of the admission (Centers for Medicare & Medicaid Services, 2024). We recognize that Medicare-Medicaid dual eligibility has limitations as a proxy for patients' income or assets because it is a dichotomous outcome and does not provide a range of values. However, the dual-eligibility status for over 65-year-old Medicare patients is valuable, as this qualification takes into account both income and assets and is consistently applied across states for the older population.
- High Area Deprivation Index status (ADI): ADI is a multidimensional measure of socioeconomic status of a geographical area (Petterson et al., 2023). It considers 17 components, comprised of 4 socioeconomic domains, including education, income/employment, housing, household characteristics. It measures at the census block group level and is calculated as a ranking from 0 to 100, with 0 meaning least deprived and 100 meaning most deprived. A census block group is a geographical unit used by the US Census Bureau and is the smallest geographical unit for which the bureau publishes sample data. The target size for block groups is 1,500, with a typical population of 600 to 3,000 people. We dichotomized the ADI rankings to greater than or equal to 85 (High ADI) versus less than 85 (Low ADI) per recommendation by the developer of ADI. For this analysis, we linked ADI at the census block group level to a 9-digit zip code.
The 17 components are listed below:
- Population aged ≥ 25 y with < 9 y of education, %
- Population aged ≥ 25 y with at least a high school diploma, %
- Employed persons aged ≥ 16 y in white-collar occupations, %
- Median family income, $
- Income disparity
- Median home value, $
- Median gross rent, $
- Median monthly mortgage, $
- Owner-occupied housing units, % (homeownership rate)
- Civilian labor force population aged ≥16 y unemployed, % (unemployment rate)
- Families below the poverty level, %
- Population below 150% of the poverty threshold, %
- Single-parent households with children aged < 18 y, %
- Households without a motor vehicle, %
- Households without a telephone, %
- Occupied housing units without complete plumbing, % (log)
- Households with more than 1 person per room, % (crowding)
References
Alvarez, P. M., McKeon, J. F., Spitzer, A. I., Krueger, C. A., Pigott, M., Li, M., & Vajapey, S. P. (2022). Socioeconomic factors affecting outcomes in total knee and hip arthroplasty: a systematic review on healthcare disparities. Arthroplasty, 4(1), 36.
Blum AB, Egorova NN, Sosunov EA, et al. Impact of socioeconomic status measures on hospital profiling in New York City. Circulation Cardiovascular quality and outcomes 2014; 7:391-7.
Centers for Medicare & Medicaid Services. (2024). Dually eligible Individuals – categories. https://www.cms.gov/medicare-medicaid-coordination/medicare-and-medicaid-coordination/medicare-medicaid-coordination-office/downloads/medicaremedicaidenrolleecategories.pdf
Courtney M, Huddleston J, Iorio R, Markel D. Socioeconomic Risk Adjustment Models for Reimbursement Are Necessary in Primary Total Joint Arthroplasty. July 2016; 32(1):1-5. https://doi.org/10.1016/j.arth.2016.06.050.
Fahrenbach, J., Chin, M. H., Huang, E. S., Springman, M. K., Weber, S. G., & Tung, E. L. (2020). Neighborhood Disadvantage and Hospital Quality Ratings in the Medicare Hospital Compare Program. Medical care, 58(4), 376–383. https://doi.org/10.1097/MLR.0000000000001283
Gilman M, Adams EK, Hockenberry JM, et al. California safety-net hospitals likely to be penalized by ACA value, readmission, and meaningful-use programs. Health Aff (Millwood). Aug 2014; 33(8):1314-22.
Herrin J, Kenward K, Joshi MS, Audet AM, Hines SJ. Assessing Community Quality of Health Care. Health Serv Res. 2016 Feb;51(1):98-116. doi: 10.1111/1475-6773.12322. Epub 2015 Jun 11. PMID: 26096649; PMCID: PMC4722214.
Herrin J, St Andre J, Kenward K, Joshi MS, Audet AM, Hines SC. Community factors and hospital readmission rates. Health Serv Res. 2015 Feb;50(1):20-39. doi: 10.1111/1475-6773.12177. Epub 2014 Apr 9. PMID: 24712374; PMCID: PMC4319869.
Jha AK, Orav EJ, Epstein AM. Low-quality, high-cost hospitals, mainly in South, care for sharply higher shares of elderly black, Hispanic, and medicaid patients. Health affairs 2011; 30:1904-11.
Joynt KE, Jha AK. Characteristics of hospitals receiving penalties under the Hospital Readmissions Reduction Program. JAMA. Jan 23 2013; 309(4):342-3.
Krumholz HM, Coppi AC, Warner F, et al. Comparative effectiveness of new approaches to improve mortality risk models from Medicare claims data. JAMA Network Open. 2019;2(7):e197314-e197314.
Martsolf G, Barrett M, Weiss A, Kandrack R, Washington R, Steiner C, Mehrotra A, SooHoo N, Coffey R. Impact of Race/Ethnicity and Socioeconomic Status on Risk-Adjusted Hospital Readmission Rates Following Hip and Knee Arthroplasty, The Journal of Bone and Joint Surgery. 2016;98(16):1385-1391. https://doi.org/10.2106/JBJS.15.00884.
Petterson S. Deciphering the Neighborhood Atlas Area Deprivation Index: the consequences of not standardizing. Health Aff Sch. 2023 Nov 3;1(5):qxad063. doi: 10.1093/haschl/qxad063. PMID: 38756979; PMCID: PMC10986280.
Pope GC, Ellis RP, Ash AS, et al. Diagnostic cost group hierarchical condition category models for Medicare risk adjustment. Final Report to the Health Care Financing Administration under Contract Number 500-95-048. 2001; http://www.cms.hhs.gov/Reports/downloads/pope_2000_2.pdf.
Pope GC, Kautter J, Ingber MJ, et al. Evaluation of the CMS-HCC Risk Adjustment Model: Final Report. 2011; https://www.cms.gov/Medicare/HealthPlans/MedicareAdvtgSpecRateStats/downloads/evaluation_risk_adj_model_2011.pdf.
Rudisill, S. S., Varady, N. H., Birir, A., Goodman, S. M., Parks, M. L., & Amen, T. B. (2023). Racial and ethnic disparities in total joint arthroplasty care: A contemporary systematic review and meta-analysis. The Journal of Arthroplasty, 38(1), 171-187.e18. https://doi.org/10.1016/j.arth.2022.08.006
Silber JH, Rosenbaum PR, Reiter JG, Jain S, Ramadan OI, Hill AS, Hashemi S, Kelz RR, Fleisher LA. The Safety of Performing Surgery at Ambulatory Surgery Centers Versus Hospital Outpatient Departments in Older Patients With or Without Multimorbidity. Med Care. 2023 May 1;61(5):328-337. doi:10.1097/MLR.0000000000001836. Epub 2023 Mar 17. PMID: 36929758; PMCID: PMC10079624.
Suleiman, L. I., Tucker, K., Ihekweazu, U., Huddleston, J. I., & Cohen-Rosenblum, A. R. (2022). Caring for diverse and high-risk patients: Surgeon, health system, and patient integration. The Journal of Arthroplasty, 37(8), 1421–1425. https://doi.org/10.1016/j.arth.2022.04.077
Usiskin, I., & Misra, D. (2022). Racial disparities in elective total joint arthroplasty for osteoarthritis. ACR Open Rheumatology, 4(4), 306–311. https://doi.org/10.1002/acr2.11399
White, R.S., Sastow, D.L., Gaber-Baylis, L.K. et al. Readmission Rates and Diagnoses Following Total Hip Replacement in Relation to Insurance Payer Status, Race and Ethnicity, and Income Status. J. Racial and Ethnic Health Disparities 5, 1202–1214 (2018). https://doi.org/10.1007/s40615-018-0467-0.
Xu HF, White RS, Sastow DL, Andreae MH, Gaber-Baylis LK, Turnbull ZA. Medicaid insurance as primary payer predicts increased mortality after total hip replacement in the state inpatient databases of California, Florida and New York. J Clin Anesth. 2017;43:24‐32. doi:10.1016/j.jclinane.2017.09.008.
Table 8 (see All Figures and Tables attachment) shows the risk variable frequencies and odds ratios for the risk variables in the final model. Risk variables are also provided within the attached data dictionary (Table 3. HK Comp All Risk Variables and Table 4. HK Comp RVs Defined by ICD10s).
Table 2 from the Social Risk Factor Testing Report attachment shows the patient-level prevalence of the DE and high ADI variables for patients attributed to ECs and EC Groups. Across attributed patients, about 3% have the DE variable, and about 9% have the ADI variable.
Table 8 (see All Figures and Tables attachment) shows the prevalence of risk variable and odds ratios for the final model risk variables. Because patient-level analyses for ECs and EC groups are based on the same patient-level model, and virtually the same set of patients, we show one set of results for all patient-level analyses.
Social Risk Factor Testing
Because the risk of an outcome conferred by clinical risk variables can overlap with the risk associated with social risk factors (see conceptual model in Section 5.4.2) we separately considered social risk factors and the relationships between clinical and social risk factors for the THA/TKA Complications measure for ECs and EC Groups.
To understand the incremental impact of social risk factors on the THA/TKA Complications measure, we assessed the following: prevalence of each social risk factor (DE, high ADI) among ECs/EC groups, association with the unadjusted outcome, odds ratios in a bivariate and multivariable model, model calibration for patients with each social risk factor, and impact on measure scores. Each analysis is described in more detail below. All analyses used the April 1, 2019, and March 31, 2022, dataset. Please see the Social Risk Factor Testing Report for all related figures and tables.
Prevalence across ECs/EC Groups
We report data for ECs/EC Groups with a minimum procedural volume of 20 cases. At the EC level, the median proportion of patients with the DE variable was 1.82%, and for the high ADI variable, 5.37%. (See Table 3 in the Social Risk Factor Testing Report). For EC Groups, the median proportion of patients with the DE variable was 2.4%, and for the high ADI variable, 6.16%.
Association with unadjusted (observed) and adjusted outcomes
As shown in Table 4 and Table 5 in the Social Risk Factor Testing Report, unadjusted complication rates for patients with DE or high ADI were higher than for patients without either social risk factor. Unadjusted complication rates were about 4% for patients with the DE variable, compared with about 2.6% for patients without the DE variable. Unadjusted complication rates were about 3% for patients with the high ADI variable, compared with about 2.6% for patients without the high ADI variable.
Similarly, odds ratios (ORs) for patients with and without either variable in a multivariable model were greater than one, and significant; ORs for the DE variable were 1.21 (95% CI 1.13-1.29), and ORs for the ADI variable were 1.12 (95% CI, 1.08-1.17) (Table 6 in the Social Risk Factor Testing Report).
Model Calibration
We also examined model calibration for each social risk factor to determine if the risk model (without including either social risk factor) performs well for patients with each social risk factor (see Figures 2-3 in the Social Risk Factor Testing Report attachment). Overall, the results show that the model is well calibrated for both DE and ADI patients.
Impact on Measure Scores
While we see that unadjusted complication rates for patients with social risk factors are higher than for patients without social risk factors, we want to understand the impact of each variable on risk-adjusted measure scores. For these analyses, we calculated measure scores with and without each social risk factor and then calculated the differences in measure scores and the correlation between measure scores (Table 8 in Social Risk Factor Testing Report attachment). We also analyzed measure scores stratified by the proportion of patients with each social risk factor, within hospitals (see Figures 4, and 5 in Social Risk Factor Testing Report attachment).
Our measure score testing results show minimal impacts of social risk factors on measure scores. Measure scores calculated with and without social risk factors are highly correlated (Pearson correlation coefficients at or near 1) and differences between measure scores are very small (near zero) (Table 8). In addition, the distribution of measures scores for hospitals in the highest proportion of patients with social risk (4th quartile) overlaps with the distribution of the other quintiles (Figures 6-7 in Social Risk Factor Testing Report attachment).
Social Risk Factor Summary
Overall, and consistent with the literature, we found that there is a low proportion of patients with social risk factors undergoing THA/TKA procedures. While patients with social risk factors (Dual Eligibility (DE)/high Area Deprivation Index (ADI)) who do undergo THA/TKA have higher unadjusted outcomes, there is almost no impact on measure scores when adding each variable to the existing risk adjustment model. This suggests that the clinical risk variables in the existing model already account for most of the risk associated with these two social risk factors. We also found that the model performs well for patients with DE and high ADI separately.
Methods
To assess model performance, we characterized model discrimination and calibration. To assess discrimination, we computed two discrimination statistics, the c-statistic and predictive ability (Table 9. Model Performance in the All Tables and Figures attachment). For calibration, we provide calibration (risk-decile) plots (see Figure 3. Calibration plot in the All Tables and Figures attachment).
The c-statistic is the probability that predicting the outcome is better than chance, which is a measure of how accurately a statistical model can distinguish between a patient with and without an outcome.
Predictive ability measures the ability to distinguish high-risk subjects from low-risk subjects; therefore, for a model with good predictive ability, we would expect to see a wide range in observed outcomes between the lowest and highest deciles of predicted outcomes. To calculate the predictive ability, we calculated the range of mean observed THA/TKA Complications between the lowest and highest predicted deciles of THA/TKA Complications probabilities.
For model calibration, we evaluated calibration plots by comparing the observed probabilities to the predicted probabilities. A model is considered well-calibrated when the predicted probabilities closely align with the observed outcomes.
Results
Please see Table 9 and Figure 3 in the All Tables and Figures attachment for the model testing results. Because patient-level analyses for ECs and EC groups are based on the same patient-level model, and virtually the same set of patients, we show one set of results for all patient-level analyses.
The c-statistic was 0.674 (Table 9 in All Tables and Figures attachment). Predictive ability ranged from 0.91% - 6.91%. Risk decile plots demonstrate good alignment between predicted probabilities and observed outcomes (Figure 3 in All Tables and Figures attachment).
Discrimination and Calibration
The c-statistic of 0.674 indicates good model discrimination. Higher deciles of the predicted outcomes are associated with higher observed outcomes, which show a good calibration of the model. The predictive ability of the model shows a wide range between the lowest decile and highest decile, indicating the ability to distinguish high-risk subjects from low-risk subjects.
Overall Interpretation
Interpreted together, our diagnostic results demonstrate the risk-adjustment model adequately controls for differences in patient characteristics (case mix).
Use & Usability
Use
Applicable level of analysis:
Clinician: Group/Practice, and
Clinician: Individual
Care Settings included:
Hospital: Inpatient,
Hospital: Outpatient, and
Ambulatory Surgery Center
Usability
The Risk-standardized Complication Rate (RSCR) following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) for Eligible Clinicians and Eligible Clinician Groups measure provides the opportunity to improve the quality of care and to lower rates of complications after THA and TKA procedures. Since THAs and TKAs are commonly performed and costly procedures, it is imperative to address their quality of care. The reevaluation of this measure to include outpatient and ASC settings is key to making this an actionable measure for clinicians. By expanding the cohort and outcome to include outpatient (HOPD and ASC) settings, the respecified THA/TKA Complications measure for ECs and EC Groups has the potential to drive clinician quality improvement and enhance care coordination for THA and TKA procedures conducted in any setting.
Improving complication rates following THA/TKA procedures involves a multifaceted approach focusing on preoperative, intraoperative, and postoperative strategies (see Logic Model attachment). Preoperatively, optimizing patient health through rigorous preoperative screening and comorbidity management can significantly reduce complications (Liu & Young, 2020). Intraoperatively, employing advanced surgical techniques and technologies, such as computer-assisted navigation and minimally invasive approaches, has been shown to decrease complication rates (Biau et al., 2019). Postoperatively, enhancing recovery protocols, including early mobilization and comprehensive rehabilitation, helps prevent complications such as deep vein thrombosis and joint stiffness (Pagnano & Hanssen, 2018). Additionally, adherence to infection prevention measures, such as antibiotic prophylaxis and sterile techniques, is crucial for minimizing the risk of periprosthetic infections (Kurtz et al., 2021). Collectively, these strategies contribute to better outcomes and reduced complication rates for THA and TKA patients.
There are evidence-based interventions that can reduce complication rates after THA/TKA. These interventions often address improvements in critical aspects of care, such as communication between providers, rapid response to complications, a focus on patient safety, and coordinated transitions to the outpatient environment (Kurtz et al., 2021; Kurtz et al., 2018). Several studies indicate that implementing quality improvement efforts, including multidisciplinary care teams, pre‐ and post‐counseling and education around THA/TKA procedures, and shared decision‐making, can reduce complications and overall associated costs of THA/TKA procedures (Kulshrestha et al., 2022; Sorensen et al., 2019; Wong et al., 2022).
A patient-centered approach that includes preoperative education, optimization of health, and adherence to rehabilitation protocols is crucial. Educating patients about their roles in minimizing risks is important; studies show that preoperative education can significantly enhance patient outcomes by ensuring better understanding and adherence to postoperative care (Kurtz et al., 2018).
A timely health evaluation and efficient preoperative care for patients might facilitate the early identification of potential risk factors, such as untreated comorbidities. Research shows that timely and efficient action to manage conditions, such as diabetes and obesity, can significantly lower infection rates and enhance overall health outcomes for THA/TKA patients (Antonelli & Chen, 2019; Giorgino et al., 2021; Ahmad et al., 2022). Another aspect of providing high-quality care is using evidence-based recommendations in perioperative care, such as implementing standardized care protocols for pain management and mobility improvement. For instance, enhanced recovery after surgery (ERAS) protocols, which place a strong emphasis on early mobilization and multimodal analgesia, have been associated with reduced complication rates for THA/TKA patients (Kaye et al., 2019; Li et al., 2019; Choi et al., 2022).
The THA/TKA complications measure for ECs and EC Groups is part of the Merit-based Incentive Payment System (MIPS), within the Quality Payment Program (QPP), a pay-for-performance program; while CMS calculates results for all EC and EC Groups. This measure addresses an important quality measurement area and enhances the information available to clinicians and clinicians’ groups to make visible meaningful quality differences and incentivizes improvement.
References
Ahmad, M. A., Ab Rahman, S., & Islam, M. A. (2022). Prevalence and risk of infection in patients with diabetes following primary total knee arthroplasty: A global systematic review and meta-analysis of 120,754 knees. Journal of Clinical Medicine, 11(13), 3752. https://doi.org/10.3390/jcm11133752
Antonelli, B., & Chen, A. F. (2019). Reducing the risk of infection after total joint arthroplasty: Preoperative optimization. Arthroplasty, 1, Article 4. https://doi.org/10.1186/s42836-019-0005-8
Biau, D. J., Tournoux, C., & Nizard, R. (2019). Computer-assisted navigation in total knee arthroplasty: A systematic review and meta-analysis. Journal of Bone and Joint Surgery, 101(5), 438-445. https://doi.org/10.2106/JBJS.18.00635
Choi, Y. S., Kim, T. W., Chang, M. J., Kang, S. B., & Chang, C. B. (2022). Enhanced recovery after surgery for major orthopedic surgery: A narrative review. Knee Surgery & Related Research, 34, 8. https://doi.org/10.1186/s43019-022-00137-3
Giorgino, F., Bhana, S., Czupryniak, L., Dagdelen, S., Galstyan, G. R., Janež, A., Lalić, N., Nouri, N., Rahelić, D., Stoian, A. P., & Raz, I. (2021). Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa. Diabetes Research and Clinical Practice, 172, 108617. https://doi.org/10.1016/j.diabres.2020.108617
Kaye, A. D., Urman, R. D., Rappaport, Y., Siddaiah, H., Cornett, E. M., Belani, K., Salinas, O. J., & Fox, C. J. (2019). Multimodal analgesia as an essential part of enhanced recovery protocols in the ambulatory settings. Journal of Anaesthesiology Clinical Pharmacology, 35(Suppl 1), S40–S45. https://doi.org/10.4103/joacp.JOACP_51_18
Kulshrestha, V., Sood, M., Kumar, S., Sood, N., Kumar, P., & Padhi, P. P. (2022). Does risk mitigation reduce 90‐day complications in patients undergoing total knee arthroplasty?: A cohort study. Clinics in Orthopedic Surgery, 14(1), 56.
Kurtz, S. M., Lau, E. C., Son, M. S., Chang, E. T., Zimmerli, W., & Parvizi, J. (2018). Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population. The Journal of arthroplasty, 33(10), 3238‐3245.
Kurtz, S., Ong, K., & Lau, E. (2018). Preoperative education and its effect on outcomes in total joint arthroplasty: A systematic review. Journal of Arthroplasty, 33(4), 1146-1152. https://doi.org/10.1016/j.arth.2017.10.030
Kurtz, S., Ong, K., Lau, E., et al. (2021). International utilization of infection prevention strategies in total hip and knee arthroplasty. Clinical Orthopaedics and Related Research, 479(3), 642-650. https://doi.org/10.1097/CORR.0000000000001204
Li, J., Zhu, H., & Liao, R. (2019). Enhanced recovery after surgery (ERAS) pathway for primary hip and knee arthroplasty: Study protocol for a randomized controlled trial. Trials, 20, 599. https://doi.org/10.1186/s13063-019-3706-8
Liu, J. L., & Young, A. M. (2020). Preoperative optimization and its effect on outcomes in total joint arthroplasty. Orthopedic Clinics of North America, 51(2), 215-223. https://doi.org/10.1016/j.ocl.2019.12.003
Pagnano, M. W., & Hanssen, A. D. (2018). Enhanced recovery after surgery (ERAS) protocols for total knee arthroplasty: A systematic review. Knee Surgery, Sports Traumatology, Arthroscopy, 26(2), 450-457. https://doi.org/10.1007/s00167-017-4542-2
Sorensen, L., Idemoto, L., Streifel, J., Williams, B., Mecklenburg, R., & Blackmore, C. (2019). A multifaceted intervention to improve the quality of care for patients undergoing total joint arthroplasty. BMJ open quality, 8(3), e000664.
Wong, W., Bridges, C., Serebin, M., Gordon, A., Jones, S., Ebert, T., & Scheidt, K. (2022). A quality improvement project to decrease length of Stay after total hip and total knee arthroplasty surgery at a veteran affairs academic medical center. Perioperative Care and Operating Room Management, 26, 100230
Stakeholders can submit questions and issues to CMS through an online tool (Q&A tool) available to the public on QualityNet and through the QPP Service Center. CMS responds to each question submitted by stakeholders. Stakeholders have asked for assistance with their questions, including understanding measure specifications (inclusion, exclusion, risk adjustment, and attribution). Through feedback via other mechanisms (such as CBE-related meetings and feedback) stakeholders have requested that CMS expand the inclusion criteria to include outpatient procedures and expand the outcome to include visits to ASCs and HOPDs.
Each year, we review and consider issues raised through the Q&A or in the literature related to this measure, and those issues are considered by measure and clinical experts. Any issues that warrant additional analytic work due to potential changes in the measure specifications are addressed as a part of annual measure reevaluation. If small changes are indicated after additional analytic work is complete, those changes are usually incorporated into the measure in the next measurement period. If the changes are substantial CMS may propose the changes through rulemaking and adopt the changes only after CMS receives public comment on the changes and finalizes those changes in rulemaking.
Each year we also review and consider changes to the Current Procedural Terminology (CPT) and International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) codes that are then incorporated into the measure. Those code set files are made available to the public on the Quality Payment Program website.
For this round of measure updates, we responded to two major points of feedback that reflect a change in the patterns of healthcare service delivery:
- Expanding the measure’s cohort inclusion criteria to include outpatient procedures.
- Expanding the measure’s outcome to include complications occurring during return visits to ASC and HOPD.
The THA/TKA Complications measure for ECs and EC Groups under consideration has been extensively respecified and has not yet been implemented; we, therefore, cannot provide information about improvement on this measure.
We provide, however, a comparison of the distribution of risk-standardized complication rates (RSCRs) from the Hospital-level THA/TKA Complications measure (CBE #1550 in its prior FFS-only form, which has as the same target patient population and the same inclusion/exclusion criteria), across different time periods. Table 10 (in the "All Figures and Tables THA TKA Complications" attachment) shows improvement in the distribution of risk-standardized scores across four time periods. This improvement in both RSCRs can also be seen from a density plot of performance overtime (see Figure 4 in the "All Figures and Tables THA TKA Complications" attachment).
Note: We do not include more recent data for comparison because in 2021 the measure went through a specification update that added complication codes to the outcome resulting in an increase in the outcome rate.
There have been no unexpected findings, negative or positive, during the implementation of this measure, including unintended impacts on patients.
Comments
Staff Preliminary Assessment
CBE #3493 Staff Preliminary Assessment
Importance
Strengths
- A clear logic model is provided, depicting the relationships between inputs (e.g., risk assessment tools, measure performance data), activities (e.g., conducting perioperative assessments, receiving performance data for trends), and desired outcomes (e.g., decreases in post-surgical complications and readmissions, improved patient health status). This model demonstrates how the measure's implementation will lead to the anticipated outcomes.
- The submission notes the complications following total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures are not common, with estimates ranging from 0.2% to 3.0%. However, the developer posits that since the number of these costly procedures is increasing (estimated to reach 1.26 million by 2030) and complications are modifiable, this focus should be measured.
- The measure is supported by cited literature, including several empirical studies demonstrating a potential net benefit in terms of reduced complications post-TKA and -THA.
- Current data from April 1, 2019, through March 31, 2022 show some variation in performance for both the clinician-level, or eligible clinician (EC), (the 10th percentile is 2.07% and the 90th percentile is 3.42%) and the clinician group/practice-level, or EC group, (the 10th percentile is 2.19% and the 90th percentile is 3.20%). About 50% of patients included in the data fall in the lower 3 deciles (i.e., better performers), which is only 30% of providers. However, the developer argues that there is meaningful variation by calculating an odds ratio, showing 1.5 times and 1.3 times increased odds of a person having a complication at a higher-risk EC or EC group, respectively, compared to lower-risk EC or EC group.
Limitations
- A potential limitation with respect to the logic model is that the assumptions draw attention to resources that may not be universal for a clinician- and clinician group-level measure (e.g., pre- and post-discharge interventions [e.g., case management, telemonitoring], investment in health care infrastructure to support high-quality care, including staff).
- The developer notes that these procedures are costly, and that reducing these complications can lead to reduced cost burden to payers and patients. However, this claim could be strengthened by providing estimates of these potential cost savings using the performance gap data provided.
- Although the developer did not collect direct patient feedback regarding the meaningfulness of the measure focus, they posit the measure’s importance to patients as this measure provides information for decision-making. The developer should consider obtaining more direct input from patients.
Rationale
- The maintenance measure is rated as 'Met' due to its robust logic model, evidence base, and continued existence of a performance gap. The submission could be strengthened, however, by gaining feedback from ECs and EC groups on the feasibility of resources identified in the assumptions within the logic model, by providing estimates of the cost savings gained with respect to the performance gap data, and by collecting direct patient input or other evidence indicating direct patient feedback on the meaningfulness of the measure focus.
Closing Care Gaps
The developer did not address this optional domain.
Feasibility Assessment
Strengths
- All required data elements are routinely generated during care delivery, and required elements are available in claims, which is an electronic data source, in structured fields.
- The re-specification of this previously endorsed measure includes expanding the measure cohort and outcome definition to include the increasing number of procedures performed in hospital outpatient and ambulatory surgery center (ASC) settings. The developer indicated that the changes made to the measure "during re-specification do not impact data availability or burden considerations."
- The developer notes that there are no costs or other burdens with this measure, as it is calculated (by CMS) automatically from claims data. There are also no patient confidentiality concerns, as this claims-based measure is submitted by ECs and EC groups to CMS. Lastly, this measure is not proprietary and has no proprietary components.
Limitations
- The developer notes the COVID-19 exclusion will not be included once implemented, but submission testing includes this exclusion. According to the Endorsement & Maintenance Guidebook, this is a material change that would result in off-cycle review.
Rationale
- This maintenance measure meets all criteria for 'Met' due to the data elements being derived in structured fields from electronic sources during the normal process of care. The measure has minimal impact on provider burden and there are no concerns with patient confidentiality. The measures is also not proprietary. These factors collectively ensure that the measure can be implemented effectively and sustainably in a real-world healthcare setting.
The developer should be advised, however, that a changes to the measure specification (e.g., COVID-19 exclusion) is a material change that may need to undergo the CBE's off-cycle review process.
Scientific Acceptability
Strengths
- The developer performed the required reliability testing for this maintenance measure, namely, they provided evidence of accountable entity-level (“measure score”) reliability testing at the level for which the measure is specified. Data sources used for reliability analysis are adequately described and include Medicare administrative claims data during the period of April 1, 2019-March 31, 2022. The entities included in the analysis were characterized by 15,575 clinicians with at least 20 cases and 4604 clinician groups with at least 20 cases.
Limitations
- The developer conducted permutation resampling to calculate the ICC at the accountable entity-level. The overall ICC for clinicians was 0.598. Although the developer did not provide decile tables of entity-level reliability, it can be inferred that less than 50% of the clinicians meet the expected threshold of 0.6. The overall ICC for clinician groups was 0.802. Because the developer did not provide decile tables of entity-level reliability, it is unclear what percentage of the clinician groups meet the expected threshold of 0.6. The developer provided an interpretation of these results, stating that the overall ICC values of 0.598 and of 0.802 show that the measure is sufficiently reliable for public reporting for clinicians or clinician groups with more than 20 cases.
Rationale
- The reliability testing results are insufficient for this maintenance measure. However, the identified limitations are deemed addressable, as the developer may consider applying the Spearman-Brown prophecy formula to estimate entity level reliability for clinician groups to demonstrate the percentage that meet the threshold of 0.6. The developer may also consider increasing the minimum number of cases when applying the measure to clinicians to increase the reliability at the clinician level.
Strengths
- Validity: The developer provides an Importance Table, Logic Model, known groups, and face validity, providing a plausible causal association between the entity response to the measure and the measure focus. Empirical support for ruling out confounders includes adequate reliability, and adequate risk-adjustment. The developer provides empirical support for ruling-in responsible mechanisms with a volume-outcome association by decile. In particular, the volume-outcome relationship accelerates in Deciles 8-10. The developer also includes several empirical studies and reports (e.g. preoperative care, intraoperative care, postoperative care, multidisciplinary care teams).
- Risk adjustment (RA): The developer conducted statistical risk adjustment, based on a conceptual model, selecting risk factors that have a significant correlation with the outcome. The developer also explored social factors, including dual eligibility and Area Deprivation Index. The developer did not include these factors in the final models due to the minimal impact these social risk factors have on the measure scores and to the model overall.
Limitations
- Validity: There is no direct empirical support for ruling out confounders outside of the reliability- and risk-adjustment. Residual risk for confounders not ruled out includes (frailty of the surgical population, socioeconomic status and social support, emergency department or inpatient encounters unrelated to surgery). Residual risk for a responsible mechanism includes the potential counter-acting mechanisms (availability of multidisciplinary care teams, infrastructure for monitoring and responding to early warning signs).
- RA: The developer reported a c-statistic of 0.674, indicating moderate model discrimination.
Rationale
- MET justification (validity): The measure developer provides strong support for the causal claim that the entity response to the measure is causally related to the measure focus. The developer provides empirical support for ruling out confounders (always with some residual risk of unstated or unexamined confounders) and for ruling in responsible mechanisms (always with some residual risk that the explicit mechanisms are only partially responsible for the measure focus).
- MET justification (RA): The risk adjustment methods are appropriate and demonstrate that variation in the prevalence of risk factors contribute to unique variation in the outcome. The model performance is acceptable.
Use and Usability
Strengths
- The measure is currently used in the CMS Merit-based Incentive Payment System (MIPS).
- The developer provides a summary of actions accountable entities can take to improve the measure focus and these actions are included in the logic model.
- For feedback mechanisms, there is a clear process outlined and described. Two changes were identified, which include: 1) expanding the measure’s cohort inclusion criteria to include outpatient procedures;
2) expanding the measure’s outcomes to include complications occurring during return visits to ASCs and hospital outpatient departments (HOPDs). - The developer reported that there have been no unexpected findings, negative or positive, during the implementation of this measure, including unintended impacts on patients.
Limitations
- The logic model also notes the use of performance data and evaluation of trends in performance for quality improvement purposes. However, the narrative does not describe this in any way. The submission could be strengthened by providing a summary of how ECs and EC groups can use the performance results to improve their care. A potential limitation is that the developer's assumptions draw attention to resources that may not be universal for a clinician- and clinician group-level (e.g., pre- and post-discharge interventions [e.g., case management, telemonitoring], investment in health care infrastructure to support high-quality care, including staff). As noted in the importance domain, the submission could be strengthened with input from accountable entities on the feasibility of these resources.
- The developer did not provide performance trends for this respecified measure as it has not been implemented. The developer did provide trend data for a similar THA/TKA complications measure for the hospital inpatient setting, CBE #1550, indicating improvement in risk-standardized scores across four time periods. However, this submission could be strengthened with trend data from the current measure (i.e., without the respecifications).
Rationale
- For maintenance, the measure is actively used in at least one accountability application. The developer also identified various actions accountable entities can take to improve the measure focus, which are reflected in the logic model. However, the submission could be improved by summarizing how ECs and EC groups can use performance results to enhance care. The developer's assumptions about resources may not be universal, and input from accountable entities on resource feasibility would strengthen the submission. The developer did not provide performance trends for the respecified measure, but trend data for a similar measure shows improvement. Including trend data from the current measure would enhance the submission.
Public Comments
RSCR following Elective THA and TKA
The American Medical Association (AMA) is concerned that the data used for measure testing (April 1, 2019-March 31,2022) overlaps with the Covid-19 public health emergency (PHE), leading us to question whether these data are likely representative of typical care outside of a PHE. We also believe that a case minimum of above 20 admissions must be required as a part of endorsement of this measure. This minimum would ensure that the measure’s minimum intra-class correlation coefficient is close to 0.6, which is what we believe should be the standard for endorsed measures.
Response to AMA's Public Comment: AMI EDAC
We thank the AMA for their input.
We agree with the commenter that unintended consequences of measurement should always be considered and monitored.
For AMI specifically, however, empiric data show the opposite of the commenter’s concerns. In fact, better (30-day) risk-adjusted AMI readmission (and AMI EDAC) measure scores are associated with better (lower) AMI mortality.
Specifically, a 2017 analysis in 1.2 million Medicare FFS patients hospitalized for AMI found that there was a weak positive correlation between (30-day) risk-adjusted AMI readmission and AMI mortality, meaning that lower (better) readmission rates were associated with lower mortality rates [1]. Similarly, a 2018 study found that following the implementation of the Hospital Readmission Reduction Program (HRRP), there was no increase in risk-adjusted in-hospital or 30-day mortality; between 2006 and 2014 in-hospital mortality decreased for AMI from 10.4% to 9.7%, and 30-day post-discharge mortality decreased from 7.4% to 7.0% (p-value for trend < .001) [2]. A 2019 MedPAC study had similar findings [3].
For AMI EDAC specifically, we recently examined the association between 30-day risk adjusted AMI mortality and AMI EDAC measure scores in about 1,500 hospitals (using the April 2025 release, most recent data publicly available on https://data.cms.gov/provider-data/search?theme=Hospitals) and found that there is a week, positive association between AMI mortality and AMI EDAC measure scores; lower (better) AMI EDAC measure scores are significantly, although weakly, associated with lower (better) AMI Mortality measure scores; Pearson correlation between the AMI EDAC and the AMI Mortality across 1,580 hospitals was 0.066, p=.008).
References
1. Dharmarajan K, Wang Y, Lin Z, Normand ST, Ross JS, Horwitz LI, Desai NR, Suter LG, Drye EE, Bernheim SM, Krumholz HM. Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge. JAMA. 2017 Jul 18;318(3):270-278. doi: 10.1001/jama.2017.8444. PMID: 28719692; PMCID: PMC5817448.
2. Khera R, Dharmarajan K, Wang Y, Lin Z, Bernheim SM, Wang Y, Normand ST, Krumholz HM. Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia. JAMA Netw Open. 2018 Sep 7;1(5):e182777. doi: 10.1001/jamanetworkopen.2018.2777. PMID: 30646181; PMCID: PMC6324473.
3. MedPAC, Update: MedPAC’s evaluation of Medicare’s Hospital Readmission Reduction Program, 2019. https://www.medpac.gov/update-medpac-s-evaluation-of-medicare-s-hospital-readmission-reduction-program/#:~:text=,a%20real%20improvement%20in%20mortality